id	sid	tid	token	lemma	pos
blsr-16013	1	1	microsoft	microsoft	PROPN
blsr-16013	1	2	word	word	PROPN
blsr-16013	1	3	ulziibold_final_blsr.docx	ulziibold_final_blsr.docx	VERB
blsr-16013	1	4	bellarmine	bellarmine	PROPN
blsr-16013	1	5	law	law	NOUN
blsr-16013	1	6	society	society	NOUN
blsr-16013	1	7	review	review	NOUN
blsr-16013	1	8	volume	volume	NOUN
blsr-16013	1	9	xiii	xiii	PUNCT
blsr-16013	2	1	|	|	ADV
blsr-16013	2	2	issue	issue	NOUN
blsr-16013	2	3	i	i	PRON
blsr-16013	2	4	article	article	NOUN
blsr-16013	2	5	1	1	NUM
blsr-16013	2	6	intellectual	intellectual	ADJ
blsr-16013	2	7	property	property	NOUN
blsr-16013	2	8	rights	right	NOUN
blsr-16013	2	9	on	on	ADP
blsr-16013	2	10	covid-19	covid-19	PROPN
blsr-16013	2	11	vaccines	vaccine	NOUN
blsr-16013	2	12	in	in	ADP
blsr-16013	2	13	the	the	DET
blsr-16013	2	14	u.s	u.s	PROPN
blsr-16013	2	15	.	.	PROPN
blsr-16013	2	16	sunderya	sunderya	PROPN
blsr-16013	2	17	ulziibold	ulziibold	PROPN
blsr-16013	2	18	boston	boston	PROPN
blsr-16013	2	19	college	college	PROPN
blsr-16013	2	20	,	,	PUNCT
blsr-16013	2	21	ulziibol@bc.edu	ulziibol@bc.edu	PROPN
blsr-16013	2	22	4	4	NUM
blsr-16013	2	23	intellectual	intellectual	ADJ
blsr-16013	2	24	property	property	NOUN
blsr-16013	2	25	rights	right	NOUN
blsr-16013	2	26	on	on	ADP
blsr-16013	2	27	covid-19	covid-19	PROPN
blsr-16013	2	28	vaccines	vaccine	NOUN
blsr-16013	2	29	in	in	ADP
blsr-16013	2	30	the	the	DET
blsr-16013	2	31	u.s	u.s	PROPN
blsr-16013	2	32	.	.	PROPN
blsr-16013	2	33	sunderya	sunderya	PROPN
blsr-16013	2	34	ulziibold	ulziibold	VERB
blsr-16013	3	1	*	*	PUNCT
blsr-16013	3	2	abstract	abstract	ADJ
blsr-16013	3	3	:	:	PUNCT
blsr-16013	3	4	the	the	DET
blsr-16013	3	5	global	global	ADJ
blsr-16013	3	6	development	development	NOUN
blsr-16013	3	7	and	and	CCONJ
blsr-16013	3	8	distribution	distribution	NOUN
blsr-16013	3	9	of	of	ADP
blsr-16013	3	10	covid-19	covid-19	PROPN
blsr-16013	3	11	vaccines	vaccine	NOUN
blsr-16013	3	12	have	have	AUX
blsr-16013	3	13	raised	raise	VERB
blsr-16013	3	14	concerns	concern	NOUN
blsr-16013	3	15	over	over	ADP
blsr-16013	3	16	intellectual	intellectual	ADJ
blsr-16013	3	17	property	property	NOUN
blsr-16013	3	18	rights	right	NOUN
blsr-16013	3	19	in	in	ADP
blsr-16013	3	20	the	the	DET
blsr-16013	3	21	united	united	PROPN
blsr-16013	3	22	states	states	PROPN
blsr-16013	3	23	.	.	PUNCT
blsr-16013	4	1	in	in	ADP
blsr-16013	4	2	particular	particular	ADJ
blsr-16013	4	3	,	,	PUNCT
blsr-16013	4	4	the	the	DET
blsr-16013	4	5	two	two	NUM
blsr-16013	4	6	pharmaceutical	pharmaceutical	ADJ
blsr-16013	4	7	giants	giant	NOUN
blsr-16013	4	8	,	,	PUNCT
blsr-16013	4	9	pfizer	pfizer	NOUN
blsr-16013	4	10	/	/	SYM
blsr-16013	4	11	biontech	biontech	PROPN
blsr-16013	4	12	and	and	CCONJ
blsr-16013	4	13	moderna	moderna	PROPN
blsr-16013	4	14	,	,	PUNCT
blsr-16013	4	15	have	have	AUX
blsr-16013	4	16	been	be	AUX
blsr-16013	4	17	embroiled	embroil	VERB
blsr-16013	4	18	in	in	ADP
blsr-16013	4	19	a	a	DET
blsr-16013	4	20	contentious	contentious	ADJ
blsr-16013	4	21	dispute	dispute	NOUN
blsr-16013	4	22	over	over	ADP
blsr-16013	4	23	the	the	DET
blsr-16013	4	24	intellectual	intellectual	ADJ
blsr-16013	4	25	property	property	NOUN
blsr-16013	4	26	rights	right	NOUN
blsr-16013	4	27	surrounding	surround	VERB
blsr-16013	4	28	their	their	PRON
blsr-16013	4	29	covid-19	covid-19	PROPN
blsr-16013	4	30	vaccine	vaccine	NOUN
blsr-16013	4	31	technology	technology	NOUN
blsr-16013	4	32	since	since	SCONJ
blsr-16013	4	33	august	august	PROPN
blsr-16013	4	34	2022	2022	NUM
blsr-16013	4	35	.	.	PUNCT
blsr-16013	5	1	the	the	DET
blsr-16013	5	2	stakes	stake	NOUN
blsr-16013	5	3	are	be	AUX
blsr-16013	5	4	high	high	ADJ
blsr-16013	5	5	,	,	PUNCT
blsr-16013	5	6	as	as	SCONJ
blsr-16013	5	7	the	the	DET
blsr-16013	5	8	outcome	outcome	NOUN
blsr-16013	5	9	of	of	ADP
blsr-16013	5	10	this	this	DET
blsr-16013	5	11	legal	legal	ADJ
blsr-16013	5	12	battle	battle	NOUN
blsr-16013	5	13	could	could	AUX
blsr-16013	5	14	determine	determine	VERB
blsr-16013	5	15	who	who	PRON
blsr-16013	5	16	ultimately	ultimately	ADV
blsr-16013	5	17	controls	control	VERB
blsr-16013	5	18	this	this	DET
blsr-16013	5	19	newfound	newfound	NOUN
blsr-16013	5	20	and	and	CCONJ
blsr-16013	5	21	lucrative	lucrative	ADJ
blsr-16013	5	22	market	market	NOUN
blsr-16013	5	23	.	.	PUNCT
blsr-16013	6	1	this	this	DET
blsr-16013	6	2	paper	paper	NOUN
blsr-16013	6	3	delves	delve	VERB
blsr-16013	6	4	into	into	ADP
blsr-16013	6	5	the	the	DET
blsr-16013	6	6	legal	legal	ADJ
blsr-16013	6	7	framework	framework	NOUN
blsr-16013	6	8	of	of	ADP
blsr-16013	6	9	intellectual	intellectual	ADJ
blsr-16013	6	10	property	property	NOUN
blsr-16013	6	11	rights	right	NOUN
blsr-16013	6	12	in	in	ADP
blsr-16013	6	13	the	the	DET
blsr-16013	6	14	united	united	PROPN
blsr-16013	6	15	states	states	PROPN
blsr-16013	6	16	as	as	SCONJ
blsr-16013	6	17	they	they	PRON
blsr-16013	6	18	apply	apply	VERB
blsr-16013	6	19	to	to	ADP
blsr-16013	6	20	covid-19	covid-19	PROPN
blsr-16013	6	21	vaccines	vaccine	NOUN
blsr-16013	6	22	.	.	PUNCT
blsr-16013	7	1	it	it	PRON
blsr-16013	7	2	also	also	ADV
blsr-16013	7	3	raises	raise	VERB
blsr-16013	7	4	critical	critical	ADJ
blsr-16013	7	5	ethical	ethical	ADJ
blsr-16013	7	6	questions	question	NOUN
blsr-16013	7	7	about	about	ADP
blsr-16013	7	8	the	the	DET
blsr-16013	7	9	implications	implication	NOUN
blsr-16013	7	10	of	of	ADP
blsr-16013	7	11	these	these	DET
blsr-16013	7	12	rights	right	NOUN
blsr-16013	7	13	for	for	ADP
blsr-16013	7	14	public	public	ADJ
blsr-16013	7	15	health	health	NOUN
blsr-16013	7	16	and	and	CCONJ
blsr-16013	7	17	access	access	NOUN
blsr-16013	7	18	to	to	ADP
blsr-16013	7	19	lifesaving	lifesaving	NOUN
blsr-16013	7	20	treatments	treatment	NOUN
blsr-16013	7	21	.	.	PUNCT
blsr-16013	8	1	by	by	ADP
blsr-16013	8	2	examining	examine	VERB
blsr-16013	8	3	these	these	DET
blsr-16013	8	4	issues	issue	NOUN
blsr-16013	8	5	,	,	PUNCT
blsr-16013	8	6	this	this	DET
blsr-16013	8	7	paper	paper	NOUN
blsr-16013	8	8	sheds	shed	VERB
blsr-16013	8	9	light	light	NOUN
blsr-16013	8	10	on	on	ADP
blsr-16013	8	11	the	the	DET
blsr-16013	8	12	ongoing	ongoing	ADJ
blsr-16013	8	13	tension	tension	NOUN
blsr-16013	8	14	between	between	ADP
blsr-16013	8	15	incentivizing	incentivize	VERB
blsr-16013	8	16	innovation	innovation	NOUN
blsr-16013	8	17	and	and	CCONJ
blsr-16013	8	18	ensuring	ensure	VERB
blsr-16013	8	19	equitable	equitable	ADJ
blsr-16013	8	20	access	access	NOUN
blsr-16013	8	21	to	to	ADP
blsr-16013	8	22	crucial	crucial	ADJ
blsr-16013	8	23	medical	medical	ADJ
blsr-16013	8	24	breakthroughs	breakthrough	NOUN
blsr-16013	8	25	.	.	PUNCT
blsr-16013	9	1	introduction	introduction	NOUN
blsr-16013	9	2	this	this	DET
blsr-16013	9	3	paper	paper	NOUN
blsr-16013	9	4	discusses	discuss	VERB
blsr-16013	9	5	the	the	DET
blsr-16013	9	6	legal	legal	ADJ
blsr-16013	9	7	issue	issue	NOUN
blsr-16013	9	8	of	of	ADP
blsr-16013	9	9	intellectual	intellectual	ADJ
blsr-16013	9	10	property	property	NOUN
blsr-16013	9	11	rights	right	NOUN
blsr-16013	9	12	on	on	ADP
blsr-16013	9	13	covid-19	covid-19	PROPN
blsr-16013	9	14	vaccines	vaccine	NOUN
blsr-16013	9	15	in	in	ADP
blsr-16013	9	16	the	the	DET
blsr-16013	9	17	u.s	u.s	PROPN
blsr-16013	9	18	.	.	PROPN
blsr-16013	9	19	beginning	begin	VERB
blsr-16013	9	20	with	with	ADP
blsr-16013	9	21	a	a	DET
blsr-16013	9	22	description	description	NOUN
blsr-16013	9	23	of	of	ADP
blsr-16013	9	24	the	the	DET
blsr-16013	9	25	industry	industry	NOUN
blsr-16013	9	26	in	in	ADP
blsr-16013	9	27	the	the	DET
blsr-16013	9	28	u.s	u.s	PROPN
blsr-16013	9	29	.	.	PROPN
blsr-16013	9	30	and	and	CCONJ
blsr-16013	9	31	the	the	DET
blsr-16013	9	32	world	world	NOUN
blsr-16013	9	33	.	.	PUNCT
blsr-16013	10	1	from	from	ADP
blsr-16013	10	2	there	there	ADV
blsr-16013	10	3	,	,	PUNCT
blsr-16013	10	4	i	i	PRON
blsr-16013	10	5	explain	explain	VERB
blsr-16013	10	6	intellectual	intellectual	ADJ
blsr-16013	10	7	property	property	NOUN
blsr-16013	10	8	and	and	CCONJ
blsr-16013	10	9	patent	patent	NOUN
blsr-16013	10	10	laws	law	NOUN
blsr-16013	10	11	in	in	ADP
blsr-16013	10	12	the	the	DET
blsr-16013	10	13	u.s	u.s	PROPN
blsr-16013	10	14	.	.	PROPN
blsr-16013	10	15	before	before	ADP
blsr-16013	10	16	moving	move	VERB
blsr-16013	10	17	on	on	ADP
blsr-16013	10	18	to	to	ADP
blsr-16013	10	19	a	a	DET
blsr-16013	10	20	description	description	NOUN
blsr-16013	10	21	of	of	ADP
blsr-16013	10	22	new	new	ADJ
blsr-16013	10	23	mrna	mrna	PROPN
blsr-16013	10	24	technology	technology	NOUN
blsr-16013	10	25	used	use	VERB
blsr-16013	10	26	for	for	ADP
blsr-16013	10	27	covid-19	covid-19	PROPN
blsr-16013	10	28	vaccines	vaccine	NOUN
blsr-16013	10	29	and	and	CCONJ
blsr-16013	10	30	its	its	PRON
blsr-16013	10	31	patentability	patentability	NOUN
blsr-16013	10	32	through	through	ADP
blsr-16013	10	33	an	an	DET
blsr-16013	10	34	analysis	analysis	NOUN
blsr-16013	10	35	of	of	ADP
blsr-16013	10	36	an	an	DET
blsr-16013	10	37	ongoing	ongoing	ADJ
blsr-16013	10	38	patent	patent	NOUN
blsr-16013	10	39	infringement	infringement	NOUN
blsr-16013	10	40	lawsuit	lawsuit	NOUN
blsr-16013	10	41	filed	file	VERB
blsr-16013	10	42	by	by	ADP
blsr-16013	10	43	modern	modern	ADJ
blsr-16013	10	44	against	against	ADP
blsr-16013	10	45	pfizer	pfizer	NOUN
blsr-16013	10	46	/	/	SYM
blsr-16013	10	47	biontech	biontech	PROPN
blsr-16013	10	48	.	.	PUNCT
blsr-16013	11	1	i.	i.	PROPN
blsr-16013	11	2	description	description	NOUN
blsr-16013	11	3	of	of	ADP
blsr-16013	11	4	the	the	DET
blsr-16013	11	5	covid-19	covid-19	PROPN
blsr-16013	11	6	vaccine	vaccine	NOUN
blsr-16013	11	7	industry	industry	NOUN
blsr-16013	11	8	the	the	DET
blsr-16013	11	9	u.s	u.s	PROPN
blsr-16013	11	10	.	.	PROPN
blsr-16013	11	11	covid-19	covid-19	PROPN
blsr-16013	11	12	vaccine	vaccine	NOUN
blsr-16013	11	13	industry	industry	NOUN
blsr-16013	11	14	was	be	AUX
blsr-16013	11	15	formed	form	VERB
blsr-16013	11	16	in	in	ADP
blsr-16013	11	17	early	early	ADJ
blsr-16013	11	18	2020	2020	NUM
blsr-16013	11	19	when	when	SCONJ
blsr-16013	11	20	the	the	DET
blsr-16013	11	21	world	world	PROPN
blsr-16013	11	22	health	health	NOUN
blsr-16013	11	23	organization	organization	NOUN
blsr-16013	11	24	(	(	PUNCT
blsr-16013	11	25	who	who	PRON
blsr-16013	11	26	)	)	PUNCT
blsr-16013	11	27	declared	declare	VERB
blsr-16013	11	28	the	the	DET
blsr-16013	11	29	covid-19	covid-19	PROPN
blsr-16013	11	30	outbreak	outbreak	NOUN
blsr-16013	11	31	a	a	DET
blsr-16013	11	32	pandemic	pandemic	NOUN
blsr-16013	11	33	.	.	PUNCT
blsr-16013	12	1	to	to	PART
blsr-16013	12	2	battle	battle	VERB
blsr-16013	12	3	the	the	DET
blsr-16013	12	4	novel	novel	ADJ
blsr-16013	12	5	coronavirus	coronavirus	NOUN
blsr-16013	12	6	,	,	PUNCT
blsr-16013	12	7	pharmaceutical	pharmaceutical	ADJ
blsr-16013	12	8	companies	company	NOUN
blsr-16013	12	9	like	like	ADP
blsr-16013	12	10	astrazeneca	astrazeneca	PROPN
blsr-16013	12	11	,	,	PUNCT
blsr-16013	12	12	moderna	moderna	PROPN
blsr-16013	12	13	,	,	PUNCT
blsr-16013	12	14	pfizer	pfizer	NOUN
blsr-16013	12	15	/	/	SYM
blsr-16013	12	16	biontech	biontech	PROPN
blsr-16013	12	17	,	,	PUNCT
blsr-16013	12	18	and	and	CCONJ
blsr-16013	12	19	johnson	johnson	PROPN
blsr-16013	12	20	&	&	CCONJ
blsr-16013	12	21	johnson	johnson	PROPN
blsr-16013	12	22	were	be	AUX
blsr-16013	12	23	funded	fund	VERB
blsr-16013	12	24	by	by	ADP
blsr-16013	12	25	who	who	PRON
blsr-16013	12	26	and	and	CCONJ
blsr-16013	12	27	many	many	ADJ
blsr-16013	12	28	other	other	ADJ
blsr-16013	12	29	donors	donor	NOUN
blsr-16013	12	30	to	to	PART
blsr-16013	12	31	accelerate	accelerate	VERB
blsr-16013	12	32	the	the	DET
blsr-16013	12	33	research	research	NOUN
blsr-16013	12	34	and	and	CCONJ
blsr-16013	12	35	development	development	NOUN
blsr-16013	12	36	of	of	ADP
blsr-16013	12	37	vaccines	vaccine	NOUN
blsr-16013	12	38	.	.	PUNCT
blsr-16013	13	1	in	in	ADP
blsr-16013	13	2	december	december	PROPN
blsr-16013	13	3	of	of	ADP
blsr-16013	13	4	2020	2020	NUM
blsr-16013	13	5	,	,	PUNCT
blsr-16013	13	6	the	the	DET
blsr-16013	13	7	first	first	ADJ
blsr-16013	13	8	covid-19	covid-19	PROPN
blsr-16013	13	9	vaccine	vaccine	NOUN
blsr-16013	13	10	was	be	AUX
blsr-16013	13	11	added	add	VERB
blsr-16013	13	12	to	to	ADP
blsr-16013	13	13	the	the	DET
blsr-16013	13	14	emergency	emergency	NOUN
blsr-16013	13	15	use	use	NOUN
blsr-16013	13	16	listing	list	VERB
blsr-16013	13	17	(	(	PUNCT
blsr-16013	13	18	eul	eul	NOUN
blsr-16013	13	19	)	)	PUNCT
blsr-16013	13	20	,	,	PUNCT
blsr-16013	13	21	overseen	oversee	VERB
blsr-16013	13	22	by	by	ADP
blsr-16013	13	23	the	the	DET
blsr-16013	13	24	who	who	PRON
blsr-16013	13	25	,	,	PUNCT
blsr-16013	13	26	and	and	CCONJ
blsr-16013	13	27	distributed	distribute	VERB
blsr-16013	13	28	to	to	ADP
blsr-16013	13	29	healthcare	healthcare	PROPN
blsr-16013	13	30	*	*	PUNCT
blsr-16013	14	1	sunderya	sunderya	PROPN
blsr-16013	14	2	ulziibold	ulziibold	ADV
blsr-16013	14	3	is	be	AUX
blsr-16013	14	4	a	a	DET
blsr-16013	14	5	second	second	ADJ
blsr-16013	14	6	-	-	PUNCT
blsr-16013	14	7	year	year	NOUN
blsr-16013	14	8	student	student	NOUN
blsr-16013	14	9	at	at	ADP
blsr-16013	14	10	boston	boston	PROPN
blsr-16013	14	11	college	college	PROPN
blsr-16013	14	12	studying	study	VERB
blsr-16013	14	13	political	political	ADJ
blsr-16013	14	14	science	science	NOUN
blsr-16013	14	15	and	and	CCONJ
blsr-16013	14	16	communications	communication	NOUN
blsr-16013	14	17	.	.	PUNCT
blsr-16013	15	1	she	she	PRON
blsr-16013	15	2	is	be	AUX
blsr-16013	15	3	interested	interested	ADJ
blsr-16013	15	4	in	in	ADP
blsr-16013	15	5	the	the	DET
blsr-16013	15	6	role	role	NOUN
blsr-16013	15	7	of	of	ADP
blsr-16013	15	8	mass	mass	ADJ
blsr-16013	15	9	media	medium	NOUN
blsr-16013	15	10	in	in	ADP
blsr-16013	15	11	the	the	DET
blsr-16013	15	12	politics	politic	NOUN
blsr-16013	15	13	of	of	ADP
blsr-16013	15	14	developing	develop	VERB
blsr-16013	15	15	countries	country	NOUN
blsr-16013	15	16	.	.	PUNCT
blsr-16013	16	1	she	she	PRON
blsr-16013	16	2	would	would	AUX
blsr-16013	16	3	like	like	VERB
blsr-16013	16	4	to	to	PART
blsr-16013	16	5	express	express	VERB
blsr-16013	16	6	special	special	ADJ
blsr-16013	16	7	thanks	thank	NOUN
blsr-16013	16	8	to	to	ADP
blsr-16013	16	9	professor	professor	PROPN
blsr-16013	16	10	rachel	rachel	PROPN
blsr-16013	16	11	spooner	spooner	PROPN
blsr-16013	16	12	who	who	PRON
blsr-16013	16	13	taught	teach	VERB
blsr-16013	16	14	her	her	PRON
blsr-16013	16	15	introduction	introduction	NOUN
blsr-16013	16	16	to	to	ADP
blsr-16013	16	17	business	business	NOUN
blsr-16013	16	18	law	law	NOUN
blsr-16013	16	19	class	class	NOUN
blsr-16013	16	20	that	that	PRON
blsr-16013	16	21	she	she	PRON
blsr-16013	16	22	much	much	ADV
blsr-16013	16	23	enjoyed	enjoy	VERB
blsr-16013	16	24	and	and	CCONJ
blsr-16013	16	25	which	which	PRON
blsr-16013	16	26	further	far	ADV
blsr-16013	16	27	developed	develop	VERB
blsr-16013	16	28	her	her	PRON
blsr-16013	16	29	interest	interest	NOUN
blsr-16013	16	30	in	in	ADP
blsr-16013	16	31	law	law	NOUN
blsr-16013	16	32	.	.	PUNCT
blsr-16013	17	1	5	5	NUM
blsr-16013	17	2	workers	worker	NOUN
blsr-16013	17	3	,	,	PUNCT
blsr-16013	17	4	those	those	PRON
blsr-16013	17	5	with	with	ADP
blsr-16013	17	6	high	high	ADJ
blsr-16013	17	7	-	-	PUNCT
blsr-16013	17	8	risk	risk	NOUN
blsr-16013	17	9	medical	medical	ADJ
blsr-16013	17	10	conditions	condition	NOUN
blsr-16013	17	11	,	,	PUNCT
blsr-16013	17	12	and	and	CCONJ
blsr-16013	17	13	people	people	NOUN
blsr-16013	17	14	older	old	ADJ
blsr-16013	17	15	than	than	ADP
blsr-16013	17	16	65	65	NUM
blsr-16013	17	17	.	.	PUNCT
blsr-16013	18	1	eventually	eventually	ADV
blsr-16013	18	2	,	,	PUNCT
blsr-16013	18	3	the	the	DET
blsr-16013	18	4	vaccine	vaccine	NOUN
blsr-16013	18	5	became	become	VERB
blsr-16013	18	6	available	available	ADJ
blsr-16013	18	7	for	for	ADP
blsr-16013	18	8	everyone	everyone	PRON
blsr-16013	18	9	,	,	PUNCT
blsr-16013	18	10	including	include	VERB
blsr-16013	18	11	ordinary	ordinary	ADJ
blsr-16013	18	12	citizens	citizen	NOUN
blsr-16013	18	13	and	and	CCONJ
blsr-16013	18	14	children	child	NOUN
blsr-16013	18	15	.	.	PUNCT
blsr-16013	19	1	currently	currently	ADV
blsr-16013	19	2	,	,	PUNCT
blsr-16013	19	3	11	11	NUM
blsr-16013	19	4	vaccines	vaccine	NOUN
blsr-16013	19	5	are	be	AUX
blsr-16013	19	6	listed	list	VERB
blsr-16013	19	7	on	on	ADP
blsr-16013	19	8	the	the	DET
blsr-16013	19	9	eul	eul	NOUN
blsr-16013	19	10	and	and	CCONJ
blsr-16013	19	11	have	have	AUX
blsr-16013	19	12	been	be	AUX
blsr-16013	19	13	mass	mass	ADV
blsr-16013	19	14	produced	produce	VERB
blsr-16013	19	15	and	and	CCONJ
blsr-16013	19	16	distributed	distribute	VERB
blsr-16013	19	17	to	to	ADP
blsr-16013	19	18	countries	country	NOUN
blsr-16013	19	19	all	all	ADV
blsr-16013	19	20	over	over	ADP
blsr-16013	19	21	the	the	DET
blsr-16013	19	22	world	world	NOUN
blsr-16013	19	23	.	.	PUNCT
blsr-16013	20	1	the	the	DET
blsr-16013	20	2	u.s	u.s	PROPN
blsr-16013	20	3	.	.	PROPN
blsr-16013	20	4	alone	alone	PROPN
blsr-16013	20	5	has	have	AUX
blsr-16013	20	6	approved	approve	VERB
blsr-16013	20	7	and	and	CCONJ
blsr-16013	20	8	authorized	authorize	VERB
blsr-16013	20	9	four	four	NUM
blsr-16013	20	10	vaccines	vaccine	NOUN
blsr-16013	20	11	:	:	PUNCT
blsr-16013	20	12	moderna	moderna	NOUN
blsr-16013	20	13	,	,	PUNCT
blsr-16013	20	14	pfizer	pfizer	NOUN
blsr-16013	20	15	/	/	SYM
blsr-16013	20	16	biontech	biontech	PROPN
blsr-16013	20	17	,	,	PUNCT
blsr-16013	20	18	johnson	johnson	PROPN
blsr-16013	20	19	&	&	CCONJ
blsr-16013	20	20	johnson	johnson	PROPN
blsr-16013	20	21	,	,	PUNCT
blsr-16013	20	22	and	and	CCONJ
blsr-16013	20	23	novavax	novavax	NOUN
blsr-16013	20	24	.	.	PUNCT
blsr-16013	21	1	as	as	ADP
blsr-16013	21	2	of	of	ADP
blsr-16013	21	3	november	november	PROPN
blsr-16013	21	4	2022	2022	NUM
blsr-16013	21	5	,	,	PUNCT
blsr-16013	21	6	15.477	15.477	NUM
blsr-16013	21	7	billion	billion	NUM
blsr-16013	21	8	vaccines	vaccine	NOUN
blsr-16013	21	9	were	be	AUX
blsr-16013	21	10	delivered	deliver	VERB
blsr-16013	21	11	worldwide,1	worldwide,1	NOUN
blsr-16013	21	12	and	and	CCONJ
blsr-16013	21	13	the	the	DET
blsr-16013	21	14	u.s	u.s	PROPN
blsr-16013	21	15	.	.	PROPN
blsr-16013	21	16	had	have	AUX
blsr-16013	21	17	distributed	distribute	VERB
blsr-16013	21	18	over	over	ADP
blsr-16013	21	19	905	905	NUM
blsr-16013	21	20	million	million	NUM
blsr-16013	21	21	doses	dose	NOUN
blsr-16013	21	22	and	and	CCONJ
blsr-16013	21	23	administered	administer	VERB
blsr-16013	21	24	over	over	ADP
blsr-16013	21	25	646	646	NUM
blsr-16013	21	26	million	million	NUM
blsr-16013	21	27	doses	dose	NOUN
blsr-16013	21	28	.	.	PUNCT
blsr-16013	22	1	in	in	ADP
blsr-16013	22	2	the	the	DET
blsr-16013	22	3	u.s	u.s	PROPN
blsr-16013	22	4	.	.	PROPN
blsr-16013	22	5	,	,	PUNCT
blsr-16013	22	6	pfizer	pfizer	NOUN
blsr-16013	22	7	/	/	SYM
blsr-16013	22	8	biontech	biontech	PROPN
blsr-16013	22	9	makes	make	VERB
blsr-16013	22	10	up	up	ADP
blsr-16013	22	11	56.2	56.2	NUM
blsr-16013	22	12	%	%	NOUN
blsr-16013	22	13	of	of	ADP
blsr-16013	22	14	the	the	DET
blsr-16013	22	15	covid-19	covid-19	PROPN
blsr-16013	22	16	vaccine	vaccine	NOUN
blsr-16013	22	17	market	market	NOUN
blsr-16013	22	18	while	while	SCONJ
blsr-16013	22	19	moderna	moderna	PROPN
blsr-16013	22	20	makes	make	VERB
blsr-16013	22	21	up	up	ADP
blsr-16013	22	22	37.8	37.8	NUM
blsr-16013	22	23	%	%	NOUN
blsr-16013	22	24	and	and	CCONJ
blsr-16013	22	25	the	the	DET
blsr-16013	22	26	remaining	remain	VERB
blsr-16013	22	27	6.0	6.0	NUM
blsr-16013	22	28	%	%	NOUN
blsr-16013	22	29	belongs	belong	VERB
blsr-16013	22	30	to	to	ADP
blsr-16013	22	31	novavax	novavax	NOUN
blsr-16013	22	32	and	and	CCONJ
blsr-16013	22	33	johnson&johnson.2	johnson&johnson.2	VERB
blsr-16013	22	34	the	the	DET
blsr-16013	22	35	size	size	NOUN
blsr-16013	22	36	of	of	ADP
blsr-16013	22	37	the	the	DET
blsr-16013	22	38	u.s	u.s	PROPN
blsr-16013	22	39	.	.	PROPN
blsr-16013	22	40	covid-19	covid-19	PROPN
blsr-16013	22	41	vaccine	vaccine	NOUN
blsr-16013	22	42	industry	industry	NOUN
blsr-16013	22	43	has	have	AUX
blsr-16013	22	44	grown	grow	VERB
blsr-16013	22	45	dramatically	dramatically	ADV
blsr-16013	22	46	over	over	ADP
blsr-16013	22	47	the	the	DET
blsr-16013	22	48	past	past	ADJ
blsr-16013	22	49	two	two	NUM
blsr-16013	22	50	years	year	NOUN
blsr-16013	22	51	,	,	PUNCT
blsr-16013	22	52	increasing	increase	VERB
blsr-16013	22	53	from	from	ADP
blsr-16013	22	54	a	a	DET
blsr-16013	22	55	value	value	NOUN
blsr-16013	22	56	of	of	ADP
blsr-16013	22	57	$	$	SYM
blsr-16013	22	58	190	190	NUM
blsr-16013	22	59	million	million	NUM
blsr-16013	22	60	in	in	ADP
blsr-16013	22	61	2020	2020	NUM
blsr-16013	22	62	to	to	ADP
blsr-16013	22	63	$	$	SYM
blsr-16013	22	64	10.81	10.81	NUM
blsr-16013	22	65	billion	billion	NUM
blsr-16013	22	66	in	in	ADP
blsr-16013	22	67	2021.3	2021.3	NUM
blsr-16013	22	68	ii	ii	NOUN
blsr-16013	22	69	.	.	PUNCT
blsr-16013	23	1	intellectual	intellectual	ADJ
blsr-16013	23	2	property	property	NOUN
blsr-16013	23	3	:	:	PUNCT
blsr-16013	23	4	patents	patent	NOUN
blsr-16013	23	5	iia	iia	VERB
blsr-16013	23	6	.	.	PUNCT
blsr-16013	24	1	intellectual	intellectual	ADJ
blsr-16013	24	2	property	property	NOUN
blsr-16013	24	3	rights	right	NOUN
blsr-16013	24	4	intellectual	intellectual	ADJ
blsr-16013	24	5	property	property	NOUN
blsr-16013	24	6	(	(	PUNCT
blsr-16013	24	7	ip	ip	NOUN
blsr-16013	24	8	)	)	PUNCT
blsr-16013	24	9	is	be	AUX
blsr-16013	24	10	any	any	DET
blsr-16013	24	11	product	product	NOUN
blsr-16013	24	12	of	of	ADP
blsr-16013	24	13	human	human	ADJ
blsr-16013	24	14	intellect	intellect	NOUN
blsr-16013	24	15	that	that	PRON
blsr-16013	24	16	the	the	DET
blsr-16013	24	17	law	law	NOUN
blsr-16013	24	18	protects	protect	VERB
blsr-16013	24	19	from	from	ADP
blsr-16013	24	20	unauthorized	unauthorized	ADJ
blsr-16013	24	21	use	use	NOUN
blsr-16013	24	22	by	by	ADP
blsr-16013	24	23	others	other	NOUN
blsr-16013	24	24	,	,	PUNCT
blsr-16013	24	25	which	which	PRON
blsr-16013	24	26	effectively	effectively	ADV
blsr-16013	24	27	enables	enable	VERB
blsr-16013	24	28	original	original	ADJ
blsr-16013	24	29	creators	creator	NOUN
blsr-16013	24	30	to	to	PART
blsr-16013	24	31	hold	hold	VERB
blsr-16013	24	32	a	a	DET
blsr-16013	24	33	monopoly	monopoly	NOUN
blsr-16013	24	34	on	on	ADP
blsr-16013	24	35	their	their	PRON
blsr-16013	24	36	ip.4	ip.4	ADJ
blsr-16013	24	37	ip	ip	NOUN
blsr-16013	24	38	rights	right	NOUN
blsr-16013	24	39	are	be	AUX
blsr-16013	24	40	crucial	crucial	ADJ
blsr-16013	24	41	to	to	ADP
blsr-16013	24	42	our	our	PRON
blsr-16013	24	43	society	society	NOUN
blsr-16013	24	44	as	as	SCONJ
blsr-16013	24	45	they	they	PRON
blsr-16013	24	46	encourage	encourage	VERB
blsr-16013	24	47	individuals	individual	NOUN
blsr-16013	24	48	and	and	CCONJ
blsr-16013	24	49	companies	company	NOUN
blsr-16013	24	50	to	to	PART
blsr-16013	24	51	be	be	AUX
blsr-16013	24	52	creative	creative	ADJ
blsr-16013	24	53	while	while	SCONJ
blsr-16013	24	54	offering	offer	VERB
blsr-16013	24	55	them	they	PRON
blsr-16013	24	56	protection	protection	NOUN
blsr-16013	24	57	.	.	PUNCT
blsr-16013	25	1	there	there	PRON
blsr-16013	25	2	are	be	VERB
blsr-16013	25	3	four	four	NUM
blsr-16013	25	4	ways	way	NOUN
blsr-16013	25	5	to	to	PART
blsr-16013	25	6	protect	protect	VERB
blsr-16013	25	7	intellectual	intellectual	ADJ
blsr-16013	25	8	property	property	NOUN
blsr-16013	25	9	:	:	PUNCT
blsr-16013	25	10	trademarks	trademark	NOUN
blsr-16013	25	11	,	,	PUNCT
blsr-16013	25	12	copyrights	copyright	NOUN
blsr-16013	25	13	,	,	PUNCT
blsr-16013	25	14	trade	trade	NOUN
blsr-16013	25	15	secrets	secret	NOUN
blsr-16013	25	16	,	,	PUNCT
blsr-16013	25	17	and	and	CCONJ
blsr-16013	25	18	patents	patent	NOUN
blsr-16013	25	19	.	.	PUNCT
blsr-16013	26	1	patents	patent	NOUN
blsr-16013	26	2	are	be	AUX
blsr-16013	26	3	the	the	DET
blsr-16013	26	4	“	"	PUNCT
blsr-16013	26	5	exclusive	exclusive	ADJ
blsr-16013	26	6	right	right	NOUN
blsr-16013	26	7	of	of	ADP
blsr-16013	26	8	its	its	PRON
blsr-16013	26	9	owner	owner	NOUN
blsr-16013	26	10	to	to	PART
blsr-16013	26	11	exclude	exclude	VERB
blsr-16013	26	12	others	other	NOUN
blsr-16013	26	13	from	from	ADP
blsr-16013	26	14	making	make	VERB
blsr-16013	26	15	,	,	PUNCT
blsr-16013	26	16	using	use	VERB
blsr-16013	26	17	,	,	PUNCT
blsr-16013	26	18	or	or	CCONJ
blsr-16013	26	19	selling	sell	VERB
blsr-16013	26	20	the	the	DET
blsr-16013	26	21	invention	invention	NOUN
blsr-16013	26	22	as	as	SCONJ
blsr-16013	26	23	defined	define	VERB
blsr-16013	26	24	in	in	ADP
blsr-16013	26	25	the	the	DET
blsr-16013	26	26	claims	claim	NOUN
blsr-16013	26	27	of	of	ADP
blsr-16013	26	28	the	the	DET
blsr-16013	26	29	patent	patent	NOUN
blsr-16013	26	30	for	for	ADP
blsr-16013	26	31	a	a	DET
blsr-16013	26	32	period	period	NOUN
blsr-16013	26	33	of	of	ADP
blsr-16013	26	34	time	time	NOUN
blsr-16013	26	35	.	.	PUNCT
blsr-16013	27	1	”5	”5	ADJ
blsr-16013	27	2	trademarks	trademark	NOUN
blsr-16013	27	3	and	and	CCONJ
blsr-16013	27	4	trade	trade	NOUN
blsr-16013	27	5	secrets	secret	NOUN
blsr-16013	27	6	are	be	AUX
blsr-16013	27	7	indefinite	indefinite	ADJ
blsr-16013	27	8	as	as	ADV
blsr-16013	27	9	long	long	ADV
blsr-16013	27	10	as	as	SCONJ
blsr-16013	27	11	they	they	PRON
blsr-16013	27	12	are	be	AUX
blsr-16013	27	13	in	in	ADP
blsr-16013	27	14	use	use	NOUN
blsr-16013	27	15	.	.	PUNCT
blsr-16013	28	1	copyrights	copyright	NOUN
blsr-16013	28	2	are	be	AUX
blsr-16013	28	3	valid	valid	ADJ
blsr-16013	28	4	for	for	ADP
blsr-16013	28	5	70	70	NUM
blsr-16013	28	6	years	year	NOUN
blsr-16013	28	7	plus	plus	CCONJ
blsr-16013	28	8	the	the	DET
blsr-16013	28	9	author	author	NOUN
blsr-16013	28	10	’s	’s	PART
blsr-16013	28	11	lifetime	lifetime	NOUN
blsr-16013	28	12	and	and	CCONJ
blsr-16013	28	13	95	95	NUM
blsr-16013	28	14	years	year	NOUN
blsr-16013	28	15	after	after	ADP
blsr-16013	28	16	first	first	ADJ
blsr-16013	28	17	publication	publication	NOUN
blsr-16013	28	18	if	if	SCONJ
blsr-16013	28	19	anonymous	anonymous	ADJ
blsr-16013	28	20	.	.	PUNCT
blsr-16013	29	1	patents	patent	NOUN
blsr-16013	29	2	cover	cover	VERB
blsr-16013	29	3	the	the	DET
blsr-16013	29	4	shortest	short	ADJ
blsr-16013	29	5	duration	duration	NOUN
blsr-16013	29	6	,	,	PUNCT
blsr-16013	29	7	as	as	SCONJ
blsr-16013	29	8	they	they	PRON
blsr-16013	29	9	span	span	VERB
blsr-16013	29	10	1	1	NUM
blsr-16013	29	11	“	"	PUNCT
blsr-16013	29	12	covid-19	covid-19	PROPN
blsr-16013	29	13	market	market	NOUN
blsr-16013	29	14	dashboard	dashboard	NOUN
blsr-16013	29	15	,	,	PUNCT
blsr-16013	29	16	”	"	PUNCT
blsr-16013	29	17	unicef	unicef	NOUN
blsr-16013	29	18	supply	supply	NOUN
blsr-16013	29	19	division	division	NOUN
blsr-16013	29	20	,	,	PUNCT
blsr-16013	29	21	accessed	access	VERB
blsr-16013	29	22	15	15	NUM
blsr-16013	29	23	november	november	PROPN
blsr-16013	29	24	2022	2022	NUM
blsr-16013	29	25	,	,	PUNCT
blsr-16013	29	26	https://www.unicef.org/supply/covid-19-market-dashboard	https://www.unicef.org/supply/covid-19-market-dashboard	ADJ
blsr-16013	29	27	.	.	NOUN
blsr-16013	29	28	2	2	NUM
blsr-16013	29	29	“	"	PUNCT
blsr-16013	29	30	covid	covid	PROPN
blsr-16013	29	31	data	data	PROPN
blsr-16013	29	32	tracker	tracker	PROPN
blsr-16013	29	33	,	,	PUNCT
blsr-16013	29	34	”	"	PUNCT
blsr-16013	29	35	centers	center	NOUN
blsr-16013	29	36	for	for	ADP
blsr-16013	29	37	disease	disease	NOUN
blsr-16013	29	38	control	control	NOUN
blsr-16013	29	39	and	and	CCONJ
blsr-16013	29	40	prevention	prevention	NOUN
blsr-16013	29	41	,	,	PUNCT
blsr-16013	29	42	accessed	access	VERB
blsr-16013	29	43	15	15	NUM
blsr-16013	29	44	november	november	PROPN
blsr-16013	29	45	2022	2022	NUM
blsr-16013	29	46	,	,	PUNCT
blsr-16013	29	47	https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-additional-dose-totalpop	https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-additional-dose-totalpop	NOUN
blsr-16013	29	48	.	.	PUNCT
blsr-16013	30	1	3	3	NUM
blsr-16013	30	2	“	"	PUNCT
blsr-16013	30	3	covid-19	covid-19	PROPN
blsr-16013	30	4	vaccines	vaccine	NOUN
blsr-16013	30	5	,	,	PUNCT
blsr-16013	30	6	”	"	PUNCT
blsr-16013	30	7	statista	statista	NOUN
blsr-16013	30	8	,	,	PUNCT
blsr-16013	30	9	accessed	access	VERB
blsr-16013	30	10	16	16	NUM
blsr-16013	30	11	november	november	PROPN
blsr-16013	30	12	2022	2022	NUM
blsr-16013	30	13	,	,	PUNCT
blsr-16013	30	14	https://www.statista.com/outlook/hmo/pharmaceuticals/vaccines/covid-19-vaccines/united-states	https://www.statista.com/outlook/hmo/pharmaceuticals/vaccines/covid-19-vaccines/united-state	NOUN
blsr-16013	30	15	.	.	PUNCT
blsr-16013	31	1	4	4	NUM
blsr-16013	31	2	“	"	PUNCT
blsr-16013	31	3	intellectual	intellectual	ADJ
blsr-16013	31	4	property	property	NOUN
blsr-16013	31	5	,	,	PUNCT
blsr-16013	31	6	”	"	PUNCT
blsr-16013	31	7	legal	legal	ADJ
blsr-16013	31	8	information	information	NOUN
blsr-16013	31	9	institute	institute	PROPN
blsr-16013	31	10	,	,	PUNCT
blsr-16013	31	11	cornell	cornell	PROPN
blsr-16013	31	12	law	law	PROPN
blsr-16013	31	13	school	school	NOUN
blsr-16013	31	14	,	,	PUNCT
blsr-16013	31	15	accessed	access	VERB
blsr-16013	31	16	16	16	NUM
blsr-16013	31	17	november	november	PROPN
blsr-16013	31	18	2022	2022	NUM
blsr-16013	31	19	,	,	PUNCT
blsr-16013	31	20	https://www.law.cornell.edu/wex/intellectual_property#:~:text=overview,monopoly%20in%20the%20protected%2	https://www.law.cornell.edu/wex/intellectual_property#:~:text=overview,monopoly%20in%20the%20protected%2	NOUN
blsr-16013	31	21	0property	0property	NUM
blsr-16013	31	22	.	.	PUNCT
blsr-16013	31	23	5	5	NUM
blsr-16013	31	24	rachel	rachel	PROPN
blsr-16013	31	25	spooner	spooner	PROPN
blsr-16013	31	26	,	,	PUNCT
blsr-16013	31	27	“	"	PUNCT
blsr-16013	31	28	intro+f22+ip	intro+f22+ip	NOUN
blsr-16013	31	29	,	,	PUNCT
blsr-16013	31	30	”	"	PUNCT
blsr-16013	31	31	powerpoint	powerpoint	NOUN
blsr-16013	31	32	presentation	presentation	NOUN
blsr-16013	31	33	,	,	PUNCT
blsr-16013	31	34	boston	boston	PROPN
blsr-16013	31	35	college	college	PROPN
blsr-16013	31	36	,	,	PUNCT
blsr-16013	31	37	chestnut	chestnut	PROPN
blsr-16013	31	38	hill	hill	PROPN
blsr-16013	31	39	,	,	PUNCT
blsr-16013	31	40	ma	ma	PROPN
blsr-16013	31	41	.	.	PROPN
blsr-16013	31	42	accessed	access	VERB
blsr-16013	31	43	fall	fall	NOUN
blsr-16013	31	44	2022	2022	NUM
blsr-16013	31	45	.	.	PUNCT
blsr-16013	32	1	6	6	NUM
blsr-16013	32	2	from	from	ADP
blsr-16013	32	3	14	14	NUM
blsr-16013	32	4	to	to	PART
blsr-16013	32	5	20	20	NUM
blsr-16013	32	6	years	year	NOUN
blsr-16013	32	7	depending	depend	VERB
blsr-16013	32	8	on	on	ADP
blsr-16013	32	9	the	the	DET
blsr-16013	32	10	patent	patent	NOUN
blsr-16013	32	11	type	type	NOUN
blsr-16013	32	12	.	.	PUNCT
blsr-16013	33	1	once	once	SCONJ
blsr-16013	33	2	the	the	DET
blsr-16013	33	3	patent	patent	NOUN
blsr-16013	33	4	is	be	AUX
blsr-16013	33	5	expired	expire	VERB
blsr-16013	33	6	,	,	PUNCT
blsr-16013	33	7	the	the	DET
blsr-16013	33	8	invention	invention	NOUN
blsr-16013	33	9	enters	enter	VERB
blsr-16013	33	10	the	the	DET
blsr-16013	33	11	public	public	ADJ
blsr-16013	33	12	domain	domain	NOUN
blsr-16013	33	13	and	and	CCONJ
blsr-16013	33	14	anyone	anyone	PRON
blsr-16013	33	15	can	can	AUX
blsr-16013	33	16	make	make	VERB
blsr-16013	33	17	,	,	PUNCT
blsr-16013	33	18	use	use	NOUN
blsr-16013	33	19	,	,	PUNCT
blsr-16013	33	20	or	or	CCONJ
blsr-16013	33	21	sell	sell	VERB
blsr-16013	33	22	the	the	DET
blsr-16013	33	23	product	product	NOUN
blsr-16013	33	24	.	.	PUNCT
blsr-16013	34	1	iib	iib	PROPN
blsr-16013	34	2	.	.	PUNCT
blsr-16013	34	3	patent	patent	NOUN
blsr-16013	34	4	law	law	NOUN
blsr-16013	34	5	under	under	ADP
blsr-16013	34	6	the	the	DET
blsr-16013	34	7	constitution	constitution	NOUN
blsr-16013	34	8	under	under	ADP
blsr-16013	34	9	article	article	PROPN
blsr-16013	34	10	i	i	PRON
blsr-16013	34	11	,	,	PUNCT
blsr-16013	34	12	section	section	NOUN
blsr-16013	34	13	8	8	NUM
blsr-16013	34	14	,	,	PUNCT
blsr-16013	34	15	of	of	ADP
blsr-16013	34	16	the	the	DET
blsr-16013	34	17	u.s	u.s	PROPN
blsr-16013	34	18	.	.	PROPN
blsr-16013	34	19	constitution	constitution	PROPN
blsr-16013	34	20	,	,	PUNCT
blsr-16013	34	21	congress	congress	PROPN
blsr-16013	34	22	has	have	VERB
blsr-16013	34	23	the	the	DET
blsr-16013	34	24	power	power	NOUN
blsr-16013	34	25	to	to	PART
blsr-16013	34	26	promote	promote	VERB
blsr-16013	34	27	scientific	scientific	ADJ
blsr-16013	34	28	progress	progress	NOUN
blsr-16013	34	29	by	by	ADP
blsr-16013	34	30	allowing	allow	VERB
blsr-16013	34	31	inventors	inventor	NOUN
blsr-16013	34	32	to	to	PART
blsr-16013	34	33	secure	secure	VERB
blsr-16013	34	34	exclusive	exclusive	ADJ
blsr-16013	34	35	rights	right	NOUN
blsr-16013	34	36	to	to	ADP
blsr-16013	34	37	their	their	PRON
blsr-16013	34	38	discoveries	discovery	NOUN
blsr-16013	34	39	for	for	ADP
blsr-16013	34	40	a	a	DET
blsr-16013	34	41	limited	limited	ADJ
blsr-16013	34	42	amount	amount	NOUN
blsr-16013	34	43	of	of	ADP
blsr-16013	34	44	time.6	time.6	NOUN
blsr-16013	34	45	this	this	DET
blsr-16013	34	46	law	law	NOUN
blsr-16013	34	47	is	be	AUX
blsr-16013	34	48	important	important	ADJ
blsr-16013	34	49	because	because	SCONJ
blsr-16013	34	50	it	it	PRON
blsr-16013	34	51	fosters	foster	VERB
blsr-16013	34	52	innovation	innovation	NOUN
blsr-16013	34	53	and	and	CCONJ
blsr-16013	34	54	incentivizes	incentivize	VERB
blsr-16013	34	55	individuals	individual	NOUN
blsr-16013	34	56	and	and	CCONJ
blsr-16013	34	57	companies	company	NOUN
blsr-16013	34	58	to	to	PART
blsr-16013	34	59	make	make	VERB
blsr-16013	34	60	new	new	ADJ
blsr-16013	34	61	scientific	scientific	ADJ
blsr-16013	34	62	discoveries	discovery	NOUN
blsr-16013	34	63	and	and	CCONJ
blsr-16013	34	64	advancements	advancement	NOUN
blsr-16013	34	65	that	that	PRON
blsr-16013	34	66	may	may	AUX
blsr-16013	34	67	be	be	AUX
blsr-16013	34	68	helpful	helpful	ADJ
blsr-16013	34	69	to	to	ADP
blsr-16013	34	70	the	the	DET
blsr-16013	34	71	world	world	NOUN
blsr-16013	34	72	.	.	PUNCT
blsr-16013	35	1	moreover	moreover	ADV
blsr-16013	35	2	,	,	PUNCT
blsr-16013	35	3	inventors	inventor	NOUN
blsr-16013	35	4	can	can	AUX
blsr-16013	35	5	gain	gain	VERB
blsr-16013	35	6	profit	profit	NOUN
blsr-16013	35	7	due	due	ADP
blsr-16013	35	8	to	to	ADP
blsr-16013	35	9	the	the	DET
blsr-16013	35	10	exclusive	exclusive	ADJ
blsr-16013	35	11	rights	right	NOUN
blsr-16013	35	12	that	that	PRON
blsr-16013	35	13	protect	protect	VERB
blsr-16013	35	14	their	their	PRON
blsr-16013	35	15	inventions	invention	NOUN
blsr-16013	35	16	.	.	PUNCT
blsr-16013	36	1	iib(i	iib(i	X
blsr-16013	36	2	)	)	PUNCT
blsr-16013	36	3	.	.	PUNCT
blsr-16013	37	1	patent	patent	NOUN
blsr-16013	37	2	act	act	NOUN
blsr-16013	37	3	of	of	ADP
blsr-16013	37	4	1952	1952	NUM
blsr-16013	37	5	the	the	DET
blsr-16013	37	6	patent	patent	NOUN
blsr-16013	37	7	act	act	NOUN
blsr-16013	37	8	of	of	ADP
blsr-16013	37	9	1952	1952	NUM
blsr-16013	37	10	requires	require	VERB
blsr-16013	37	11	that	that	SCONJ
blsr-16013	37	12	a	a	DET
blsr-16013	37	13	patent	patent	NOUN
blsr-16013	37	14	must	must	AUX
blsr-16013	37	15	be	be	AUX
blsr-16013	37	16	novel	novel	ADJ
blsr-16013	37	17	,	,	PUNCT
blsr-16013	37	18	non	non	ADJ
blsr-16013	37	19	-	-	ADJ
blsr-16013	37	20	obvious	obvious	ADJ
blsr-16013	37	21	,	,	PUNCT
blsr-16013	37	22	useful	useful	ADJ
blsr-16013	37	23	,	,	PUNCT
blsr-16013	37	24	and	and	CCONJ
blsr-16013	37	25	a	a	DET
blsr-16013	37	26	valid	valid	ADJ
blsr-16013	37	27	subject	subject	NOUN
blsr-16013	37	28	matter	matter	NOUN
blsr-16013	37	29	.	.	PUNCT
blsr-16013	38	1	“	"	PUNCT
blsr-16013	38	2	novel	novel	NOUN
blsr-16013	38	3	”	"	PUNCT
blsr-16013	38	4	means	mean	VERB
blsr-16013	38	5	the	the	DET
blsr-16013	38	6	patent	patent	NOUN
blsr-16013	38	7	should	should	AUX
blsr-16013	38	8	propose	propose	VERB
blsr-16013	38	9	something	something	PRON
blsr-16013	38	10	new	new	ADJ
blsr-16013	38	11	,	,	PUNCT
blsr-16013	38	12	like	like	ADP
blsr-16013	38	13	an	an	DET
blsr-16013	38	14	innovative	innovative	ADJ
blsr-16013	38	15	technology	technology	NOUN
blsr-16013	38	16	or	or	CCONJ
blsr-16013	38	17	a	a	DET
blsr-16013	38	18	scientific	scientific	ADJ
blsr-16013	38	19	discovery	discovery	NOUN
blsr-16013	38	20	.	.	PUNCT
blsr-16013	39	1	it	it	PRON
blsr-16013	39	2	must	must	AUX
blsr-16013	39	3	be	be	AUX
blsr-16013	39	4	non	non	ADJ
blsr-16013	39	5	-	-	ADJ
blsr-16013	39	6	obvious	obvious	ADJ
blsr-16013	39	7	“	"	PUNCT
blsr-16013	39	8	to	to	ADP
blsr-16013	39	9	a	a	DET
blsr-16013	39	10	person	person	NOUN
blsr-16013	39	11	of	of	ADP
blsr-16013	39	12	ordinary	ordinary	ADJ
blsr-16013	39	13	skill	skill	NOUN
blsr-16013	39	14	and	and	CCONJ
blsr-16013	39	15	knowledge	knowledge	NOUN
blsr-16013	39	16	in	in	ADP
blsr-16013	39	17	the	the	DET
blsr-16013	39	18	art	art	NOUN
blsr-16013	39	19	or	or	CCONJ
blsr-16013	39	20	technology	technology	NOUN
blsr-16013	39	21	to	to	PART
blsr-16013	39	22	which	which	PRON
blsr-16013	39	23	the	the	DET
blsr-16013	39	24	invention	invention	NOUN
blsr-16013	39	25	is	be	AUX
blsr-16013	39	26	related	relate	VERB
blsr-16013	39	27	.	.	PUNCT
blsr-16013	39	28	”7	”7	PUNCT
blsr-16013	40	1	the	the	DET
blsr-16013	40	2	usefulness	usefulness	NOUN
blsr-16013	40	3	of	of	ADP
blsr-16013	40	4	the	the	DET
blsr-16013	40	5	invention	invention	NOUN
blsr-16013	40	6	is	be	AUX
blsr-16013	40	7	determined	determine	VERB
blsr-16013	40	8	by	by	ADP
blsr-16013	40	9	its	its	PRON
blsr-16013	40	10	intended	intended	ADJ
blsr-16013	40	11	purpose	purpose	NOUN
blsr-16013	40	12	.	.	PUNCT
blsr-16013	41	1	a	a	DET
blsr-16013	41	2	valid	valid	ADJ
blsr-16013	41	3	subject	subject	NOUN
blsr-16013	41	4	matter	matter	NOUN
blsr-16013	41	5	must	must	AUX
blsr-16013	41	6	not	not	PART
blsr-16013	41	7	be	be	AUX
blsr-16013	41	8	abstract	abstract	ADJ
blsr-16013	41	9	,	,	PUNCT
blsr-16013	41	10	the	the	DET
blsr-16013	41	11	product	product	NOUN
blsr-16013	41	12	of	of	ADP
blsr-16013	41	13	nature	nature	NOUN
blsr-16013	41	14	,	,	PUNCT
blsr-16013	41	15	or	or	CCONJ
blsr-16013	41	16	within	within	ADP
blsr-16013	41	17	the	the	DET
blsr-16013	41	18	laws	law	NOUN
blsr-16013	41	19	of	of	ADP
blsr-16013	41	20	nature	nature	NOUN
blsr-16013	41	21	.	.	PUNCT
blsr-16013	42	1	a	a	DET
blsr-16013	42	2	patent	patent	NOUN
blsr-16013	42	3	can	can	AUX
blsr-16013	42	4	be	be	AUX
blsr-16013	42	5	found	find	VERB
blsr-16013	42	6	invalid	invalid	ADJ
blsr-16013	42	7	if	if	SCONJ
blsr-16013	42	8	it	it	PRON
blsr-16013	42	9	does	do	AUX
blsr-16013	42	10	not	not	PART
blsr-16013	42	11	fulfill	fulfill	VERB
blsr-16013	42	12	all	all	DET
blsr-16013	42	13	four	four	NUM
blsr-16013	42	14	requirements	requirement	NOUN
blsr-16013	42	15	.	.	PUNCT
blsr-16013	43	1	iic	iic	PROPN
blsr-16013	43	2	.	.	PUNCT
blsr-16013	43	3	patent	patent	NOUN
blsr-16013	43	4	infringement	infringement	NOUN
blsr-16013	43	5	patent	patent	NOUN
blsr-16013	43	6	infringement	infringement	NOUN
blsr-16013	43	7	occurs	occur	VERB
blsr-16013	43	8	when	when	SCONJ
blsr-16013	43	9	the	the	DET
blsr-16013	43	10	owner	owner	NOUN
blsr-16013	43	11	of	of	ADP
blsr-16013	43	12	the	the	DET
blsr-16013	43	13	patent	patent	NOUN
blsr-16013	43	14	files	file	VERB
blsr-16013	43	15	a	a	DET
blsr-16013	43	16	suit	suit	NOUN
blsr-16013	43	17	for	for	ADP
blsr-16013	43	18	infringement	infringement	NOUN
blsr-16013	43	19	for	for	ADP
blsr-16013	43	20	unauthorized	unauthorized	ADJ
blsr-16013	43	21	use	use	NOUN
blsr-16013	43	22	of	of	ADP
blsr-16013	43	23	their	their	PRON
blsr-16013	43	24	patent	patent	NOUN
blsr-16013	43	25	,	,	PUNCT
blsr-16013	43	26	and	and	CCONJ
blsr-16013	43	27	obtains	obtain	VERB
blsr-16013	43	28	appropriate	appropriate	ADJ
blsr-16013	43	29	monetary	monetary	ADJ
blsr-16013	43	30	damages	damage	NOUN
blsr-16013	43	31	and	and	CCONJ
blsr-16013	43	32	injunctive	injunctive	ADJ
blsr-16013	43	33	relief	relief	NOUN
blsr-16013	43	34	.	.	PUNCT
blsr-16013	44	1	iii	iii	X
blsr-16013	44	2	.	.	PROPN
blsr-16013	44	3	ip	ip	PROPN
blsr-16013	44	4	and	and	CCONJ
blsr-16013	44	5	covid-19	covid-19	PROPN
blsr-16013	44	6	vaccines	vaccine	NOUN
blsr-16013	44	7	iiia	iiia	VERB
blsr-16013	44	8	.	.	PUNCT
blsr-16013	45	1	mrna	mrna	PROPN
blsr-16013	45	2	and	and	CCONJ
blsr-16013	45	3	patentability	patentability	NOUN
blsr-16013	45	4	there	there	PRON
blsr-16013	45	5	are	be	VERB
blsr-16013	45	6	three	three	NUM
blsr-16013	45	7	main	main	ADJ
blsr-16013	45	8	types	type	NOUN
blsr-16013	45	9	of	of	ADP
blsr-16013	45	10	covid-19	covid-19	PROPN
blsr-16013	45	11	vaccines	vaccine	NOUN
blsr-16013	45	12	approved	approve	VERB
blsr-16013	45	13	in	in	ADP
blsr-16013	45	14	the	the	DET
blsr-16013	45	15	united	united	PROPN
blsr-16013	45	16	states	states	PROPN
blsr-16013	45	17	:	:	PUNCT
blsr-16013	45	18	“	"	PUNCT
blsr-16013	45	19	messenger	messenger	NOUN
blsr-16013	45	20	rna	rna	PROPN
blsr-16013	45	21	(	(	PUNCT
blsr-16013	45	22	mrna	mrna	PROPN
blsr-16013	45	23	)	)	PUNCT
blsr-16013	45	24	,	,	PUNCT
blsr-16013	45	25	viral	viral	ADJ
blsr-16013	45	26	vector	vector	NOUN
blsr-16013	45	27	,	,	PUNCT
blsr-16013	45	28	and	and	CCONJ
blsr-16013	45	29	protein	protein	NOUN
blsr-16013	45	30	subunit	subunit	NOUN
blsr-16013	45	31	.	.	PUNCT
blsr-16013	45	32	”8	”8	PUNCT
blsr-16013	46	1	while	while	SCONJ
blsr-16013	46	2	mrna	mrna	PROPN
blsr-16013	46	3	technology	technology	NOUN
blsr-16013	46	4	is	be	AUX
blsr-16013	46	5	new	new	ADJ
blsr-16013	46	6	to	to	ADP
blsr-16013	46	7	the	the	DET
blsr-16013	46	8	field	field	NOUN
blsr-16013	46	9	,	,	PUNCT
blsr-16013	46	10	viral	viral	ADJ
blsr-16013	46	11	vector	vector	NOUN
blsr-16013	46	12	and	and	CCONJ
blsr-16013	46	13	protein	protein	NOUN
blsr-16013	46	14	subunit	subunit	NOUN
blsr-16013	46	15	vaccine	vaccine	NOUN
blsr-16013	46	16	technologies	technology	NOUN
blsr-16013	46	17	have	have	AUX
blsr-16013	46	18	long	long	ADV
blsr-16013	46	19	been	be	AUX
blsr-16013	46	20	used	use	VERB
blsr-16013	46	21	6	6	NUM
blsr-16013	46	22	twomey	twomey	NOUN
blsr-16013	46	23	,	,	PUNCT
blsr-16013	46	24	david	david	PROPN
blsr-16013	46	25	p.	p.	PROPN
blsr-16013	46	26	,	,	PUNCT
blsr-16013	46	27	“	"	PUNCT
blsr-16013	46	28	chapter	chapter	NOUN
blsr-16013	46	29	9	9	NUM
blsr-16013	46	30	,	,	PUNCT
blsr-16013	46	31	”	"	PUNCT
blsr-16013	46	32	in	in	ADP
blsr-16013	46	33	business	business	NOUN
blsr-16013	46	34	law	law	NOUN
blsr-16013	46	35	:	:	PUNCT
blsr-16013	46	36	principles	principle	NOUN
blsr-16013	46	37	for	for	ADP
blsr-16013	46	38	today	today	NOUN
blsr-16013	46	39	's	's	PART
blsr-16013	46	40	commercial	commercial	ADJ
blsr-16013	46	41	environment	environment	NOUN
blsr-16013	46	42	(	(	PUNCT
blsr-16013	46	43	australia	australia	PROPN
blsr-16013	46	44	:	:	PUNCT
blsr-16013	46	45	cengage	cengage	PROPN
blsr-16013	46	46	learning	learning	PROPN
blsr-16013	46	47	,	,	PUNCT
blsr-16013	46	48	2017	2017	NUM
blsr-16013	46	49	)	)	PUNCT
blsr-16013	46	50	.	.	PUNCT
blsr-16013	47	1	7	7	NUM
blsr-16013	47	2	twomey	twomey	NOUN
blsr-16013	47	3	,	,	PUNCT
blsr-16013	47	4	business	business	NOUN
blsr-16013	47	5	law	law	NOUN
blsr-16013	47	6	,	,	PUNCT
blsr-16013	47	7	chapter	chapter	NOUN
blsr-16013	47	8	9	9	NUM
blsr-16013	47	9	.	.	NOUN
blsr-16013	47	10	8	8	NUM
blsr-16013	47	11	“	"	PUNCT
blsr-16013	47	12	overview	overview	NOUN
blsr-16013	47	13	of	of	ADP
blsr-16013	47	14	covid-19	covid-19	PROPN
blsr-16013	47	15	vaccines	vaccine	NOUN
blsr-16013	47	16	,	,	PUNCT
blsr-16013	47	17	”	"	PUNCT
blsr-16013	47	18	centers	center	NOUN
blsr-16013	47	19	for	for	ADP
blsr-16013	47	20	disease	disease	NOUN
blsr-16013	47	21	control	control	NOUN
blsr-16013	47	22	and	and	CCONJ
blsr-16013	47	23	prevention	prevention	NOUN
blsr-16013	47	24	,	,	PUNCT
blsr-16013	47	25	updated	update	VERB
blsr-16013	47	26	1	1	NUM
blsr-16013	47	27	november	november	PROPN
blsr-16013	47	28	2022	2022	NUM
blsr-16013	47	29	,	,	PUNCT
blsr-16013	47	30	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-covid-19vaccines.html?s_cid=11758:types%20of%20covid%20vaccines:sem.ga:p:rg:gm:gen:ptn:fy22	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-covid-19vaccines.html?s_cid=11758:types%20of%20covid%20vaccines:sem.ga:p:rg:gm:gen:ptn:fy22	NOUN
blsr-16013	47	31	.	.	NOUN
blsr-16013	47	32	7	7	NUM
blsr-16013	47	33	and	and	CCONJ
blsr-16013	47	34	are	be	AUX
blsr-16013	47	35	considered	consider	VERB
blsr-16013	47	36	the	the	DET
blsr-16013	47	37	“	"	PUNCT
blsr-16013	47	38	traditional	traditional	ADJ
blsr-16013	47	39	”	"	PUNCT
blsr-16013	47	40	methods	method	NOUN
blsr-16013	47	41	.	.	PUNCT
blsr-16013	48	1	“	"	PUNCT
blsr-16013	48	2	mrna	mrna	PROPN
blsr-16013	48	3	vaccines	vaccine	NOUN
blsr-16013	48	4	use	use	VERB
blsr-16013	48	5	mrna	mrna	PROPN
blsr-16013	48	6	created	create	VERB
blsr-16013	48	7	in	in	ADP
blsr-16013	48	8	a	a	DET
blsr-16013	48	9	laboratory	laboratory	NOUN
blsr-16013	48	10	to	to	PART
blsr-16013	48	11	teach	teach	VERB
blsr-16013	48	12	our	our	PRON
blsr-16013	48	13	cells	cell	NOUN
blsr-16013	48	14	how	how	SCONJ
blsr-16013	48	15	to	to	PART
blsr-16013	48	16	make	make	VERB
blsr-16013	48	17	a	a	DET
blsr-16013	48	18	protein	protein	NOUN
blsr-16013	48	19	—	—	PUNCT
blsr-16013	48	20	or	or	CCONJ
blsr-16013	48	21	even	even	ADV
blsr-16013	48	22	just	just	ADV
blsr-16013	48	23	a	a	DET
blsr-16013	48	24	piece	piece	NOUN
blsr-16013	48	25	of	of	ADP
blsr-16013	48	26	a	a	DET
blsr-16013	48	27	protein	protein	NOUN
blsr-16013	48	28	—	—	PUNCT
blsr-16013	48	29	that	that	PRON
blsr-16013	48	30	triggers	trigger	VERB
blsr-16013	48	31	an	an	DET
blsr-16013	48	32	immune	immune	ADJ
blsr-16013	48	33	response	response	NOUN
blsr-16013	48	34	inside	inside	ADP
blsr-16013	48	35	our	our	PRON
blsr-16013	48	36	bodies	body	NOUN
blsr-16013	48	37	.	.	PUNCT
blsr-16013	49	1	this	this	DET
blsr-16013	49	2	immune	immune	ADJ
blsr-16013	49	3	response	response	NOUN
blsr-16013	49	4	,	,	PUNCT
blsr-16013	49	5	which	which	PRON
blsr-16013	49	6	produces	produce	VERB
blsr-16013	49	7	antibodies	antibody	NOUN
blsr-16013	49	8	,	,	PUNCT
blsr-16013	49	9	is	be	AUX
blsr-16013	49	10	what	what	PRON
blsr-16013	49	11	helps	help	VERB
blsr-16013	49	12	protect	protect	VERB
blsr-16013	49	13	us	we	PRON
blsr-16013	49	14	from	from	ADP
blsr-16013	49	15	getting	get	VERB
blsr-16013	49	16	sick	sick	ADJ
blsr-16013	49	17	from	from	ADP
blsr-16013	49	18	that	that	DET
blsr-16013	49	19	germ	germ	NOUN
blsr-16013	49	20	in	in	ADP
blsr-16013	49	21	the	the	DET
blsr-16013	49	22	future	future	NOUN
blsr-16013	49	23	.	.	PUNCT
blsr-16013	49	24	”9	”9	PUNCT
blsr-16013	50	1	while	while	SCONJ
blsr-16013	50	2	mrna	mrna	PROPN
blsr-16013	50	3	technology	technology	PROPN
blsr-16013	50	4	has	have	AUX
blsr-16013	50	5	been	be	AUX
blsr-16013	50	6	researched	research	VERB
blsr-16013	50	7	for	for	ADP
blsr-16013	50	8	decades	decade	NOUN
blsr-16013	50	9	,	,	PUNCT
blsr-16013	50	10	it	it	PRON
blsr-16013	50	11	was	be	AUX
blsr-16013	50	12	not	not	PART
blsr-16013	50	13	implemented	implement	VERB
blsr-16013	50	14	in	in	ADP
blsr-16013	50	15	vaccines	vaccine	NOUN
blsr-16013	50	16	until	until	ADP
blsr-16013	50	17	the	the	DET
blsr-16013	50	18	covid-19	covid-19	PROPN
blsr-16013	50	19	pandemic	pandemic	NOUN
blsr-16013	50	20	.	.	PUNCT
blsr-16013	51	1	similar	similar	ADJ
blsr-16013	51	2	to	to	ADP
blsr-16013	51	3	how	how	SCONJ
blsr-16013	51	4	viral	viral	ADJ
blsr-16013	51	5	vector	vector	NOUN
blsr-16013	51	6	and	and	CCONJ
blsr-16013	51	7	protein	protein	NOUN
blsr-16013	51	8	subunit	subunit	NOUN
blsr-16013	51	9	vaccine	vaccine	NOUN
blsr-16013	51	10	methods	method	NOUN
blsr-16013	51	11	have	have	AUX
blsr-16013	51	12	been	be	AUX
blsr-16013	51	13	used	use	VERB
blsr-16013	51	14	for	for	ADP
blsr-16013	51	15	effective	effective	ADJ
blsr-16013	51	16	vaccines	vaccine	NOUN
blsr-16013	51	17	in	in	ADP
blsr-16013	51	18	the	the	DET
blsr-16013	51	19	past	past	NOUN
blsr-16013	51	20	,	,	PUNCT
blsr-16013	51	21	the	the	DET
blsr-16013	51	22	mrna	mrna	PROPN
blsr-16013	51	23	method	method	NOUN
blsr-16013	51	24	can	can	AUX
blsr-16013	51	25	be	be	AUX
blsr-16013	51	26	a	a	DET
blsr-16013	51	27	new	new	ADJ
blsr-16013	51	28	way	way	NOUN
blsr-16013	51	29	of	of	ADP
blsr-16013	51	30	making	make	VERB
blsr-16013	51	31	more	more	ADV
blsr-16013	51	32	effective	effective	ADJ
blsr-16013	51	33	vaccines	vaccine	NOUN
blsr-16013	51	34	in	in	ADP
blsr-16013	51	35	the	the	DET
blsr-16013	51	36	future	future	NOUN
blsr-16013	51	37	.	.	PUNCT
blsr-16013	52	1	pfizer	pfizer	NOUN
blsr-16013	52	2	/	/	SYM
blsr-16013	52	3	biontech	biontech	PROPN
blsr-16013	52	4	and	and	CCONJ
blsr-16013	52	5	moderna	moderna	PROPN
blsr-16013	52	6	were	be	AUX
blsr-16013	52	7	the	the	DET
blsr-16013	52	8	first	first	ADJ
blsr-16013	52	9	pharmaceutical	pharmaceutical	ADJ
blsr-16013	52	10	companies	company	NOUN
blsr-16013	52	11	to	to	PART
blsr-16013	52	12	make	make	VERB
blsr-16013	52	13	effective	effective	ADJ
blsr-16013	52	14	mrna	mrna	NOUN
blsr-16013	52	15	vaccines	vaccine	NOUN
blsr-16013	52	16	for	for	ADP
blsr-16013	52	17	humans	human	NOUN
blsr-16013	52	18	.	.	PUNCT
blsr-16013	53	1	with	with	ADP
blsr-16013	53	2	an	an	DET
blsr-16013	53	3	expanding	expand	VERB
blsr-16013	53	4	global	global	ADJ
blsr-16013	53	5	vaccine	vaccine	NOUN
blsr-16013	53	6	industry	industry	NOUN
blsr-16013	53	7	,	,	PUNCT
blsr-16013	53	8	patenting	patent	VERB
blsr-16013	53	9	this	this	DET
blsr-16013	53	10	new	new	ADJ
blsr-16013	53	11	technology	technology	NOUN
blsr-16013	53	12	will	will	AUX
blsr-16013	53	13	be	be	AUX
blsr-16013	53	14	profitable	profitable	ADJ
blsr-16013	53	15	in	in	ADP
blsr-16013	53	16	the	the	DET
blsr-16013	53	17	long	long	ADJ
blsr-16013	53	18	run	run	NOUN
blsr-16013	53	19	and	and	CCONJ
blsr-16013	53	20	allow	allow	VERB
blsr-16013	53	21	patent	patent	NOUN
blsr-16013	53	22	holders	holder	NOUN
blsr-16013	53	23	to	to	PART
blsr-16013	53	24	eventually	eventually	ADV
blsr-16013	53	25	shape	shape	VERB
blsr-16013	53	26	the	the	DET
blsr-16013	53	27	future	future	NOUN
blsr-16013	53	28	of	of	ADP
blsr-16013	53	29	mrna	mrna	PROPN
blsr-16013	53	30	vaccines	vaccine	NOUN
blsr-16013	53	31	.	.	PUNCT
blsr-16013	54	1	iiib	iiib	NOUN
blsr-16013	54	2	.	.	PUNCT
blsr-16013	55	1	association	association	NOUN
blsr-16013	55	2	for	for	ADP
blsr-16013	55	3	molecular	molecular	ADJ
blsr-16013	55	4	pathology	pathology	NOUN
blsr-16013	55	5	v.	v.	ADP
blsr-16013	55	6	myriad	myriad	ADJ
blsr-16013	55	7	genetics	genetic	NOUN
blsr-16013	55	8	case	case	NOUN
blsr-16013	55	9	the	the	DET
blsr-16013	55	10	association	association	NOUN
blsr-16013	55	11	for	for	ADP
blsr-16013	55	12	molecular	molecular	ADJ
blsr-16013	55	13	pathology	pathology	NOUN
blsr-16013	55	14	and	and	CCONJ
blsr-16013	55	15	other	other	ADJ
blsr-16013	55	16	medical	medical	ADJ
blsr-16013	55	17	associations	association	NOUN
blsr-16013	55	18	sued	sue	VERB
blsr-16013	55	19	the	the	DET
blsr-16013	55	20	united	united	PROPN
blsr-16013	55	21	states	states	PROPN
blsr-16013	55	22	trademark	trademark	NOUN
blsr-16013	55	23	and	and	CCONJ
blsr-16013	55	24	patent	patent	NOUN
blsr-16013	55	25	office	office	NOUN
blsr-16013	55	26	(	(	PUNCT
blsr-16013	55	27	ustpo	ustpo	PROPN
blsr-16013	55	28	)	)	PUNCT
blsr-16013	55	29	and	and	CCONJ
blsr-16013	55	30	myriad	myriad	ADJ
blsr-16013	55	31	genetics	genetic	NOUN
blsr-16013	55	32	to	to	PART
blsr-16013	55	33	challenge	challenge	VERB
blsr-16013	55	34	its	its	PRON
blsr-16013	55	35	humangene	humangene	NOUN
blsr-16013	55	36	-	-	PUNCT
blsr-16013	55	37	related	relate	VERB
blsr-16013	55	38	patents	patent	NOUN
blsr-16013	55	39	.	.	PUNCT
blsr-16013	56	1	myriad	myriad	ADJ
blsr-16013	56	2	genetics	genetic	NOUN
blsr-16013	56	3	discovered	discover	VERB
blsr-16013	56	4	specific	specific	ADJ
blsr-16013	56	5	mutations	mutation	NOUN
blsr-16013	56	6	in	in	ADP
blsr-16013	56	7	human	human	ADJ
blsr-16013	56	8	genetics	genetic	NOUN
blsr-16013	56	9	,	,	PUNCT
blsr-16013	56	10	called	call	VERB
blsr-16013	56	11	brca1	brca1	PROPN
blsr-16013	56	12	and	and	CCONJ
blsr-16013	56	13	brca2	brca2	PROPN
blsr-16013	56	14	,	,	PUNCT
blsr-16013	56	15	that	that	PRON
blsr-16013	56	16	marked	mark	VERB
blsr-16013	56	17	a	a	DET
blsr-16013	56	18	high	high	ADJ
blsr-16013	56	19	risk	risk	NOUN
blsr-16013	56	20	of	of	ADP
blsr-16013	56	21	breast	breast	NOUN
blsr-16013	56	22	and	and	CCONJ
blsr-16013	56	23	ovarian	ovarian	ADJ
blsr-16013	56	24	cancer	cancer	NOUN
blsr-16013	56	25	.	.	PUNCT
blsr-16013	57	1	to	to	PART
blsr-16013	57	2	test	test	VERB
blsr-16013	57	3	whether	whether	SCONJ
blsr-16013	57	4	a	a	DET
blsr-16013	57	5	person	person	NOUN
blsr-16013	57	6	is	be	AUX
blsr-16013	57	7	at	at	ADP
blsr-16013	57	8	high	high	ADJ
blsr-16013	57	9	risk	risk	NOUN
blsr-16013	57	10	,	,	PUNCT
blsr-16013	57	11	it	it	PRON
blsr-16013	57	12	is	be	AUX
blsr-16013	57	13	necessary	necessary	ADJ
blsr-16013	57	14	to	to	PART
blsr-16013	57	15	isolate	isolate	VERB
blsr-16013	57	16	their	their	PRON
blsr-16013	57	17	genes	gene	NOUN
blsr-16013	57	18	.	.	PUNCT
blsr-16013	58	1	therefore	therefore	ADV
blsr-16013	58	2	,	,	PUNCT
blsr-16013	58	3	myriad	myriad	ADJ
blsr-16013	58	4	patented	patent	VERB
blsr-16013	58	5	the	the	DET
blsr-16013	58	6	process	process	NOUN
blsr-16013	58	7	that	that	PRON
blsr-16013	58	8	isolates	isolate	VERB
blsr-16013	58	9	brca1	brca1	PROPN
blsr-16013	58	10	and	and	CCONJ
blsr-16013	58	11	brca2	brca2	PROPN
blsr-16013	58	12	,	,	PUNCT
blsr-16013	58	13	which	which	PRON
blsr-16013	58	14	would	would	AUX
blsr-16013	58	15	give	give	VERB
blsr-16013	58	16	them	they	PRON
blsr-16013	58	17	the	the	DET
blsr-16013	58	18	exclusive	exclusive	ADJ
blsr-16013	58	19	right	right	NOUN
blsr-16013	58	20	to	to	ADP
blsr-16013	58	21	breast	breast	NOUN
blsr-16013	58	22	and	and	CCONJ
blsr-16013	58	23	ovarian	ovarian	ADJ
blsr-16013	58	24	cancer	cancer	NOUN
blsr-16013	58	25	testing	testing	NOUN
blsr-16013	58	26	as	as	ADV
blsr-16013	58	27	well	well	ADV
blsr-16013	58	28	as	as	ADP
blsr-16013	58	29	gene	gene	NOUN
blsr-16013	58	30	isolation	isolation	NOUN
blsr-16013	58	31	.	.	PUNCT
blsr-16013	59	1	however	however	ADV
blsr-16013	59	2	,	,	PUNCT
blsr-16013	59	3	the	the	DET
blsr-16013	59	4	u.s	u.s	PROPN
blsr-16013	59	5	.	.	PROPN
blsr-16013	59	6	supreme	supreme	PROPN
blsr-16013	59	7	court	court	PROPN
blsr-16013	59	8	ruled	rule	VERB
blsr-16013	59	9	that	that	SCONJ
blsr-16013	59	10	myriad	myriad	NOUN
blsr-16013	59	11	’s	’s	PART
blsr-16013	59	12	patents	patent	NOUN
blsr-16013	59	13	are	be	AUX
blsr-16013	59	14	invalid	invalid	ADJ
blsr-16013	59	15	because	because	SCONJ
blsr-16013	59	16	human	human	ADJ
blsr-16013	59	17	genes	gene	NOUN
blsr-16013	59	18	are	be	AUX
blsr-16013	59	19	found	find	VERB
blsr-16013	59	20	in	in	ADP
blsr-16013	59	21	nature	nature	NOUN
blsr-16013	59	22	and	and	CCONJ
blsr-16013	59	23	merely	merely	ADV
blsr-16013	59	24	isolating	isolate	VERB
blsr-16013	59	25	them	they	PRON
blsr-16013	59	26	is	be	AUX
blsr-16013	59	27	unpatentable	unpatentable	ADJ
blsr-16013	59	28	.	.	PUNCT
blsr-16013	60	1	unlike	unlike	ADP
blsr-16013	60	2	this	this	DET
blsr-16013	60	3	case	case	NOUN
blsr-16013	60	4	,	,	PUNCT
blsr-16013	60	5	the	the	DET
blsr-16013	60	6	technology	technology	NOUN
blsr-16013	60	7	of	of	ADP
blsr-16013	60	8	mrna	mrna	PROPN
blsr-16013	60	9	in	in	ADP
blsr-16013	60	10	vaccines	vaccine	NOUN
blsr-16013	60	11	is	be	AUX
blsr-16013	60	12	novel	novel	ADJ
blsr-16013	60	13	.	.	PUNCT
blsr-16013	61	1	mrna	mrna	PROPN
blsr-16013	61	2	can	can	AUX
blsr-16013	61	3	be	be	AUX
blsr-16013	61	4	found	find	VERB
blsr-16013	61	5	in	in	ADP
blsr-16013	61	6	nature	nature	NOUN
blsr-16013	61	7	as	as	SCONJ
blsr-16013	61	8	it	it	PRON
blsr-16013	61	9	is	be	AUX
blsr-16013	61	10	“	"	PUNCT
blsr-16013	61	11	genetic	genetic	ADJ
blsr-16013	61	12	material	material	NOUN
blsr-16013	61	13	that	that	PRON
blsr-16013	61	14	tells	tell	VERB
blsr-16013	61	15	your	your	PRON
blsr-16013	61	16	body	body	NOUN
blsr-16013	61	17	how	how	SCONJ
blsr-16013	61	18	to	to	PART
blsr-16013	61	19	make	make	VERB
blsr-16013	61	20	proteins,”10	proteins,”10	NOUN
blsr-16013	61	21	but	but	CCONJ
blsr-16013	61	22	for	for	ADP
blsr-16013	61	23	covid19	covid19	NOUN
blsr-16013	61	24	mrna	mrna	PROPN
blsr-16013	61	25	vaccines	vaccine	NOUN
blsr-16013	61	26	,	,	PUNCT
blsr-16013	61	27	the	the	DET
blsr-16013	61	28	mrna	mrna	PROPN
blsr-16013	61	29	is	be	AUX
blsr-16013	61	30	laboratory	laboratory	NOUN
blsr-16013	61	31	-	-	PUNCT
blsr-16013	61	32	made	make	VERB
blsr-16013	61	33	.	.	PUNCT
blsr-16013	62	1	moreover	moreover	ADV
blsr-16013	62	2	,	,	PUNCT
blsr-16013	62	3	it	it	PRON
blsr-16013	62	4	is	be	AUX
blsr-16013	62	5	nonobvious	nonobvious	ADJ
blsr-16013	62	6	to	to	ADP
blsr-16013	62	7	an	an	DET
blsr-16013	62	8	ordinary	ordinary	ADJ
blsr-16013	62	9	person	person	NOUN
blsr-16013	62	10	without	without	ADP
blsr-16013	62	11	any	any	DET
blsr-16013	62	12	knowledge	knowledge	NOUN
blsr-16013	62	13	of	of	ADP
blsr-16013	62	14	mrna	mrna	PROPN
blsr-16013	62	15	and	and	CCONJ
blsr-16013	62	16	it	it	PRON
blsr-16013	62	17	is	be	AUX
blsr-16013	62	18	useful	useful	ADJ
blsr-16013	62	19	because	because	SCONJ
blsr-16013	62	20	it	it	PRON
blsr-16013	62	21	triggers	trigger	VERB
blsr-16013	62	22	the	the	DET
blsr-16013	62	23	immune	immune	ADJ
blsr-16013	62	24	system	system	NOUN
blsr-16013	62	25	against	against	ADP
blsr-16013	62	26	a	a	DET
blsr-16013	62	27	virus	virus	NOUN
blsr-16013	62	28	.	.	PUNCT
blsr-16013	63	1	it	it	PRON
blsr-16013	63	2	is	be	AUX
blsr-16013	63	3	also	also	ADV
blsr-16013	63	4	a	a	DET
blsr-16013	63	5	valid	valid	ADJ
blsr-16013	63	6	subject	subject	NOUN
blsr-16013	63	7	matter	matter	NOUN
blsr-16013	63	8	,	,	PUNCT
blsr-16013	63	9	fulfilling	fulfil	VERB
blsr-16013	63	10	all	all	DET
blsr-16013	63	11	four	four	NUM
blsr-16013	63	12	criteria	criterion	NOUN
blsr-16013	63	13	and	and	CCONJ
blsr-16013	63	14	rendering	render	VERB
blsr-16013	63	15	the	the	DET
blsr-16013	63	16	mrna	mrna	PROPN
blsr-16013	63	17	technology	technology	NOUN
blsr-16013	63	18	patentable	patentable	ADJ
blsr-16013	63	19	.	.	PUNCT
blsr-16013	64	1	9	9	NUM
blsr-16013	64	2	“	"	PUNCT
blsr-16013	64	3	understanding	understand	VERB
blsr-16013	64	4	how	how	SCONJ
blsr-16013	64	5	covid-19	covid-19	PROPN
blsr-16013	64	6	vaccines	vaccine	NOUN
blsr-16013	64	7	work	work	VERB
blsr-16013	64	8	,	,	PUNCT
blsr-16013	64	9	”	"	PUNCT
blsr-16013	64	10	centers	center	NOUN
blsr-16013	64	11	for	for	ADP
blsr-16013	64	12	disease	disease	NOUN
blsr-16013	64	13	control	control	NOUN
blsr-16013	64	14	and	and	CCONJ
blsr-16013	64	15	prevention	prevention	NOUN
blsr-16013	64	16	,	,	PUNCT
blsr-16013	64	17	updated	update	VERB
blsr-16013	64	18	3	3	NUM
blsr-16013	64	19	february	february	NOUN
blsr-16013	64	20	2023	2023	NUM
blsr-16013	64	21	,	,	PUNCT
blsr-16013	64	22	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html	X
blsr-16013	64	23	.	.	PUNCT
blsr-16013	65	1	10	10	NUM
blsr-16013	65	2	“	"	PUNCT
blsr-16013	65	3	understanding	understand	VERB
blsr-16013	65	4	how	how	SCONJ
blsr-16013	65	5	covid-19	covid-19	PROPN
blsr-16013	65	6	vaccines	vaccine	NOUN
blsr-16013	65	7	work	work	VERB
blsr-16013	65	8	,	,	PUNCT
blsr-16013	65	9	”	"	PUNCT
blsr-16013	65	10	cdc	cdc	PROPN
blsr-16013	65	11	.	.	PROPN
blsr-16013	65	12	8	8	NUM
blsr-16013	65	13	iiic	iiic	PROPN
blsr-16013	65	14	.	.	PUNCT
blsr-16013	65	15	moderna	moderna	PROPN
blsr-16013	65	16	v.	v.	ADP
blsr-16013	65	17	pfizer	pfizer	PROPN
blsr-16013	65	18	/	/	SYM
blsr-16013	65	19	biontech	biontech	ADJ
blsr-16013	65	20	ongoing	ongoing	ADJ
blsr-16013	65	21	case	case	NOUN
blsr-16013	65	22	in	in	ADP
blsr-16013	65	23	august	august	PROPN
blsr-16013	65	24	2022	2022	NUM
blsr-16013	65	25	,	,	PUNCT
blsr-16013	65	26	nine	nine	NUM
blsr-16013	65	27	months	month	NOUN
blsr-16013	65	28	after	after	ADP
blsr-16013	65	29	the	the	DET
blsr-16013	65	30	first	first	ADJ
blsr-16013	65	31	mrna	mrna	PROPN
blsr-16013	65	32	vaccine	vaccine	NOUN
blsr-16013	65	33	,	,	PUNCT
blsr-16013	65	34	moderna	moderna	PROPN
blsr-16013	65	35	sued	sue	VERB
blsr-16013	65	36	pfizer	pfizer	NOUN
blsr-16013	65	37	/	/	SYM
blsr-16013	65	38	biontech	biontech	NOUN
blsr-16013	65	39	for	for	ADP
blsr-16013	65	40	three	three	NUM
blsr-16013	65	41	patent	patent	NOUN
blsr-16013	65	42	infringements	infringement	NOUN
blsr-16013	65	43	related	relate	VERB
blsr-16013	65	44	to	to	ADP
blsr-16013	65	45	mrna	mrna	PROPN
blsr-16013	65	46	technology	technology	PROPN
blsr-16013	65	47	.	.	PUNCT
blsr-16013	66	1	the	the	DET
blsr-16013	66	2	company	company	NOUN
blsr-16013	66	3	stated	state	VERB
blsr-16013	66	4	that	that	SCONJ
blsr-16013	66	5	“	"	PUNCT
blsr-16013	66	6	pfizer	pfizer	NOUN
blsr-16013	66	7	and	and	CCONJ
blsr-16013	66	8	biontech	biontech	PROPN
blsr-16013	66	9	’s	’s	PART
blsr-16013	66	10	covid-19	covid-19	PROPN
blsr-16013	66	11	vaccine	vaccine	NOUN
blsr-16013	66	12	comirnaty	comirnaty	NOUN
blsr-16013	66	13	infringes	infringe	VERB
blsr-16013	66	14	patents	patent	NOUN
blsr-16013	66	15	moderna	moderna	PROPN
blsr-16013	66	16	filed	file	VERB
blsr-16013	66	17	between	between	ADP
blsr-16013	66	18	2010	2010	NUM
blsr-16013	66	19	and	and	CCONJ
blsr-16013	66	20	2016	2016	NUM
blsr-16013	66	21	covering	cover	VERB
blsr-16013	66	22	moderna	moderna	PROPN
blsr-16013	66	23	’s	’s	PART
blsr-16013	66	24	foundational	foundational	PROPN
blsr-16013	66	25	mrna	mrna	PROPN
blsr-16013	66	26	technology	technology	PROPN
blsr-16013	66	27	.	.	PUNCT
blsr-16013	67	1	this	this	DET
blsr-16013	67	2	groundbreaking	groundbreake	VERB
blsr-16013	67	3	technology	technology	NOUN
blsr-16013	67	4	was	be	AUX
blsr-16013	67	5	critical	critical	ADJ
blsr-16013	67	6	to	to	ADP
blsr-16013	67	7	the	the	DET
blsr-16013	67	8	development	development	NOUN
blsr-16013	67	9	of	of	ADP
blsr-16013	67	10	moderna	moderna	PROPN
blsr-16013	67	11	’s	’s	PART
blsr-16013	67	12	own	own	ADJ
blsr-16013	67	13	mrna	mrna	PROPN
blsr-16013	67	14	covid-19	covid-19	PROPN
blsr-16013	67	15	vaccine	vaccine	NOUN
blsr-16013	67	16	,	,	PUNCT
blsr-16013	67	17	spikevax	spikevax	PROPN
blsr-16013	67	18	.	.	PUNCT
blsr-16013	68	1	pfizer	pfizer	NOUN
blsr-16013	68	2	and	and	CCONJ
blsr-16013	68	3	biontech	biontech	PROPN
blsr-16013	68	4	copied	copy	VERB
blsr-16013	68	5	this	this	DET
blsr-16013	68	6	technology	technology	NOUN
blsr-16013	68	7	,	,	PUNCT
blsr-16013	68	8	without	without	ADP
blsr-16013	68	9	moderna	moderna	PROPN
blsr-16013	68	10	’s	’s	PART
blsr-16013	68	11	permission	permission	NOUN
blsr-16013	68	12	,	,	PUNCT
blsr-16013	68	13	to	to	PART
blsr-16013	68	14	make	make	VERB
blsr-16013	68	15	comirnaty	comirnaty	NOUN
blsr-16013	68	16	.	.	PUNCT
blsr-16013	69	1	”11	”11	PROPN
blsr-16013	70	1	under	under	ADP
blsr-16013	70	2	the	the	DET
blsr-16013	70	3	patent	patent	NOUN
blsr-16013	70	4	act	act	NOUN
blsr-16013	70	5	of	of	ADP
blsr-16013	70	6	1952	1952	NUM
blsr-16013	70	7	,	,	PUNCT
blsr-16013	70	8	moderna	moderna	PROPN
blsr-16013	70	9	has	have	VERB
blsr-16013	70	10	the	the	DET
blsr-16013	70	11	right	right	NOUN
blsr-16013	70	12	to	to	PART
blsr-16013	70	13	sue	sue	VERB
blsr-16013	70	14	pfizer	pfizer	NOUN
blsr-16013	70	15	/	/	SYM
blsr-16013	70	16	biontech	biontech	NOUN
blsr-16013	70	17	for	for	ADP
blsr-16013	70	18	patent	patent	NOUN
blsr-16013	70	19	infringement	infringement	NOUN
blsr-16013	70	20	and	and	CCONJ
blsr-16013	70	21	seek	seek	VERB
blsr-16013	70	22	appropriate	appropriate	ADJ
blsr-16013	70	23	monetary	monetary	ADJ
blsr-16013	70	24	damages	damage	NOUN
blsr-16013	70	25	and	and	CCONJ
blsr-16013	70	26	injunctive	injunctive	ADJ
blsr-16013	70	27	relief	relief	NOUN
blsr-16013	70	28	.	.	PUNCT
blsr-16013	71	1	moderna	moderna	PROPN
blsr-16013	71	2	is	be	AUX
blsr-16013	71	3	seeking	seek	VERB
blsr-16013	71	4	damages	damage	NOUN
blsr-16013	71	5	,	,	PUNCT
blsr-16013	71	6	including	include	VERB
blsr-16013	71	7	royalties	royalty	NOUN
blsr-16013	71	8	and	and	CCONJ
blsr-16013	71	9	lost	lose	VERB
blsr-16013	71	10	profits	profit	NOUN
blsr-16013	71	11	incurred	incur	VERB
blsr-16013	71	12	since	since	SCONJ
blsr-16013	71	13	march	march	PROPN
blsr-16013	71	14	2022	2022	NUM
blsr-16013	71	15	and	and	CCONJ
blsr-16013	71	16	license	license	NOUN
blsr-16013	71	17	fees	fee	NOUN
blsr-16013	71	18	from	from	ADP
blsr-16013	71	19	high	high	ADJ
blsr-16013	71	20	-	-	PUNCT
blsr-16013	71	21	income	income	NOUN
blsr-16013	71	22	countries	country	NOUN
blsr-16013	71	23	.	.	PUNCT
blsr-16013	72	1	however	however	ADV
blsr-16013	72	2	,	,	PUNCT
blsr-16013	72	3	the	the	DET
blsr-16013	72	4	company	company	NOUN
blsr-16013	72	5	chose	choose	VERB
blsr-16013	72	6	not	not	PART
blsr-16013	72	7	to	to	PART
blsr-16013	72	8	seek	seek	VERB
blsr-16013	72	9	damages	damage	NOUN
blsr-16013	72	10	from	from	ADP
blsr-16013	72	11	pfizer	pfizer	NOUN
blsr-16013	72	12	’s	’s	PART
blsr-16013	72	13	sales	sale	NOUN
blsr-16013	72	14	of	of	ADP
blsr-16013	72	15	its	its	PRON
blsr-16013	72	16	vaccine	vaccine	NOUN
blsr-16013	72	17	to	to	ADP
blsr-16013	72	18	the	the	DET
blsr-16013	72	19	world	world	NOUN
blsr-16013	72	20	’s	’s	PART
blsr-16013	72	21	poorest	poor	ADJ
blsr-16013	72	22	countries	country	NOUN
blsr-16013	72	23	and	and	CCONJ
blsr-16013	72	24	the	the	DET
blsr-16013	72	25	u.s	u.s	PROPN
blsr-16013	72	26	.	.	PROPN
blsr-16013	72	27	government	government	NOUN
blsr-16013	72	28	,	,	PUNCT
blsr-16013	72	29	which	which	PRON
blsr-16013	72	30	bought	buy	VERB
blsr-16013	72	31	pfizer	pfizer	NOUN
blsr-16013	72	32	/	/	SYM
blsr-16013	72	33	biontech	biontech	NOUN
blsr-16013	72	34	vaccines.12	vaccines.12	NOUN
blsr-16013	72	35	to	to	ADP
blsr-16013	72	36	moderna	moderna	PROPN
blsr-16013	72	37	’s	’s	PART
blsr-16013	72	38	claim	claim	NOUN
blsr-16013	72	39	,	,	PUNCT
blsr-16013	72	40	pfizer	pfizer	NOUN
blsr-16013	72	41	/	/	SYM
blsr-16013	72	42	biontech	biontech	PROPN
blsr-16013	72	43	responds	respond	VERB
blsr-16013	72	44	that	that	SCONJ
blsr-16013	72	45	their	their	PRON
blsr-16013	72	46	“	"	PUNCT
blsr-16013	72	47	work	work	NOUN
blsr-16013	72	48	is	be	AUX
blsr-16013	72	49	original	original	ADJ
blsr-16013	72	50	,	,	PUNCT
blsr-16013	72	51	and	and	CCONJ
blsr-16013	72	52	[	[	X
blsr-16013	72	53	they	they	PRON
blsr-16013	72	54	]	]	PUNCT
blsr-16013	72	55	will	will	AUX
blsr-16013	72	56	vigorously	vigorously	ADV
blsr-16013	72	57	defend	defend	VERB
blsr-16013	72	58	against	against	ADP
blsr-16013	72	59	all	all	DET
blsr-16013	72	60	allegations	allegation	NOUN
blsr-16013	72	61	of	of	ADP
blsr-16013	72	62	patent	patent	NOUN
blsr-16013	72	63	infringement	infringement	NOUN
blsr-16013	72	64	.	.	PUNCT
blsr-16013	72	65	”	"	PUNCT
blsr-16013	73	1	13	13	NUM
blsr-16013	73	2	the	the	DET
blsr-16013	73	3	case	case	NOUN
blsr-16013	73	4	has	have	VERB
blsr-16013	73	5	important	important	ADJ
blsr-16013	73	6	ramifications	ramification	NOUN
blsr-16013	73	7	for	for	ADP
blsr-16013	73	8	the	the	DET
blsr-16013	73	9	future	future	ADJ
blsr-16013	73	10	profitability	profitability	NOUN
blsr-16013	73	11	of	of	ADP
blsr-16013	73	12	both	both	DET
blsr-16013	73	13	companies	company	NOUN
blsr-16013	73	14	.	.	PUNCT
blsr-16013	74	1	experts	expert	NOUN
blsr-16013	74	2	have	have	AUX
blsr-16013	74	3	already	already	ADV
blsr-16013	74	4	started	start	VERB
blsr-16013	74	5	speculating	speculate	VERB
blsr-16013	74	6	on	on	ADP
blsr-16013	74	7	the	the	DET
blsr-16013	74	8	matter	matter	NOUN
blsr-16013	74	9	and	and	CCONJ
blsr-16013	74	10	believe	believe	VERB
blsr-16013	74	11	that	that	SCONJ
blsr-16013	74	12	it	it	PRON
blsr-16013	74	13	could	could	AUX
blsr-16013	74	14	either	either	CCONJ
blsr-16013	74	15	come	come	VERB
blsr-16013	74	16	to	to	ADP
blsr-16013	74	17	a	a	DET
blsr-16013	74	18	relatively	relatively	ADV
blsr-16013	74	19	quick	quick	ADJ
blsr-16013	74	20	decision	decision	NOUN
blsr-16013	74	21	or	or	CCONJ
blsr-16013	74	22	drag	drag	VERB
blsr-16013	74	23	on	on	ADP
blsr-16013	74	24	for	for	ADP
blsr-16013	74	25	years.14	years.14	PROPN
blsr-16013	74	26	the	the	DET
blsr-16013	74	27	ruling	ruling	NOUN
blsr-16013	74	28	of	of	ADP
blsr-16013	74	29	this	this	DET
blsr-16013	74	30	ongoing	ongoing	ADJ
blsr-16013	74	31	lawsuit	lawsuit	NOUN
blsr-16013	74	32	will	will	AUX
blsr-16013	74	33	likely	likely	ADV
blsr-16013	74	34	shape	shape	VERB
blsr-16013	74	35	the	the	DET
blsr-16013	74	36	future	future	NOUN
blsr-16013	74	37	of	of	ADP
blsr-16013	74	38	mrna	mrna	PROPN
blsr-16013	74	39	technology	technology	NOUN
blsr-16013	74	40	,	,	PUNCT
blsr-16013	74	41	not	not	PART
blsr-16013	74	42	only	only	ADV
blsr-16013	74	43	in	in	ADP
blsr-16013	74	44	the	the	DET
blsr-16013	74	45	covid-19	covid-19	PROPN
blsr-16013	74	46	vaccine	vaccine	NOUN
blsr-16013	74	47	industry	industry	NOUN
blsr-16013	74	48	,	,	PUNCT
blsr-16013	74	49	but	but	CCONJ
blsr-16013	74	50	also	also	ADV
blsr-16013	74	51	in	in	ADP
blsr-16013	74	52	the	the	DET
blsr-16013	74	53	medical	medical	ADJ
blsr-16013	74	54	industry	industry	NOUN
blsr-16013	74	55	.	.	PUNCT
blsr-16013	75	1	conclusion	conclusion	NOUN
blsr-16013	75	2	intellectual	intellectual	ADJ
blsr-16013	75	3	property	property	NOUN
blsr-16013	75	4	rights	right	NOUN
blsr-16013	75	5	promote	promote	VERB
blsr-16013	75	6	and	and	CCONJ
blsr-16013	75	7	incentivize	incentivize	VERB
blsr-16013	75	8	the	the	DET
blsr-16013	75	9	covid-19	covid-19	PROPN
blsr-16013	75	10	vaccine	vaccine	NOUN
blsr-16013	75	11	industry	industry	NOUN
blsr-16013	75	12	to	to	PART
blsr-16013	75	13	flourish	flourish	VERB
blsr-16013	75	14	and	and	CCONJ
blsr-16013	75	15	develop	develop	VERB
blsr-16013	75	16	groundbreaking	groundbreake	VERB
blsr-16013	75	17	technology	technology	NOUN
blsr-16013	75	18	.	.	PUNCT
blsr-16013	76	1	however	however	ADV
blsr-16013	76	2	,	,	PUNCT
blsr-16013	76	3	patents	patent	NOUN
blsr-16013	76	4	on	on	ADP
blsr-16013	76	5	covid-19	covid-19	PROPN
blsr-16013	76	6	vaccines	vaccine	NOUN
blsr-16013	76	7	,	,	PUNCT
blsr-16013	76	8	11	11	NUM
blsr-16013	76	9	“	"	PUNCT
blsr-16013	76	10	moderna	moderna	PROPN
blsr-16013	76	11	sues	sue	NOUN
blsr-16013	76	12	pfizer	pfizer	PROPN
blsr-16013	76	13	and	and	CCONJ
blsr-16013	76	14	biontech	biontech	NOUN
blsr-16013	76	15	for	for	ADP
blsr-16013	76	16	infringing	infringe	VERB
blsr-16013	76	17	patents	patent	NOUN
blsr-16013	76	18	central	central	ADJ
blsr-16013	76	19	to	to	ADP
blsr-16013	76	20	moderna	moderna	PROPN
blsr-16013	76	21	’s	’s	PART
blsr-16013	76	22	innovative	innovative	ADJ
blsr-16013	76	23	mrna	mrna	PROPN
blsr-16013	76	24	technology	technology	NOUN
blsr-16013	76	25	platform	platform	NOUN
blsr-16013	76	26	,	,	PUNCT
blsr-16013	76	27	”	"	PUNCT
blsr-16013	76	28	moderna	moderna	PROPN
blsr-16013	76	29	,	,	PUNCT
blsr-16013	76	30	26	26	NUM
blsr-16013	76	31	august	august	PROPN
blsr-16013	76	32	2022	2022	NUM
blsr-16013	76	33	,	,	PUNCT
blsr-16013	76	34	https://investors.modernatx.com/news/news-details/2022/moderna-suespfizer-and-biontech-for-infringing-patents-central-to-modernas-innovative-mrna-technologyplatform/default.aspx	https://investors.modernatx.com/news/news-details/2022/moderna-suespfizer-and-biontech-for-infringing-patents-central-to-modernas-innovative-mrna-technologyplatform/default.aspx	X
blsr-16013	76	35	.	.	PROPN
blsr-16013	76	36	12	12	NUM
blsr-16013	76	37	rebecca	rebecca	NOUN
blsr-16013	76	38	robins	robin	NOUN
blsr-16013	76	39	and	and	CCONJ
blsr-16013	76	40	jenny	jenny	PROPN
blsr-16013	76	41	gross	gross	PROPN
blsr-16013	76	42	,	,	PUNCT
blsr-16013	76	43	“	"	PUNCT
blsr-16013	76	44	moderna	moderna	PROPN
blsr-16013	76	45	sues	sue	NOUN
blsr-16013	76	46	pfizer	pfizer	PROPN
blsr-16013	76	47	and	and	CCONJ
blsr-16013	76	48	biontech	biontech	NOUN
blsr-16013	76	49	over	over	ADP
blsr-16013	76	50	covid	covid	PROPN
blsr-16013	76	51	vaccine	vaccine	NOUN
blsr-16013	76	52	technology	technology	NOUN
blsr-16013	76	53	.	.	PUNCT
blsr-16013	76	54	”	"	PUNCT
blsr-16013	77	1	new	new	PROPN
blsr-16013	77	2	york	york	PROPN
blsr-16013	77	3	times	times	PROPN
blsr-16013	77	4	,	,	PUNCT
blsr-16013	77	5	26	26	NUM
blsr-16013	77	6	august	august	PROPN
blsr-16013	77	7	2022	2022	NUM
blsr-16013	77	8	,	,	PUNCT
blsr-16013	77	9	https://www.nytimes.com/2022/08/26/business/moderna-covid-vaccine-lawsuit.html	https://www.nytimes.com/2022/08/26/business/moderna-covid-vaccine-lawsuit.html	PROPN
blsr-16013	77	10	.	.	PROPN
blsr-16013	77	11	13	13	NUM
blsr-16013	77	12	“	"	PUNCT
blsr-16013	77	13	press	press	NOUN
blsr-16013	77	14	release	release	NOUN
blsr-16013	77	15	:	:	PUNCT
blsr-16013	77	16	statement	statement	NOUN
blsr-16013	77	17	on	on	ADP
blsr-16013	77	18	patent	patent	NOUN
blsr-16013	77	19	infringement	infringement	NOUN
blsr-16013	77	20	lawsuit	lawsuit	NOUN
blsr-16013	77	21	filed	file	VERB
blsr-16013	77	22	by	by	ADP
blsr-16013	77	23	moderna	moderna	PROPN
blsr-16013	77	24	,	,	PUNCT
blsr-16013	77	25	”	"	PUNCT
blsr-16013	77	26	biontech	biontech	NOUN
blsr-16013	77	27	,	,	PUNCT
blsr-16013	77	28	26	26	NUM
blsr-16013	77	29	august	august	PROPN
blsr-16013	77	30	2022	2022	NUM
blsr-16013	77	31	,	,	PUNCT
blsr-16013	77	32	https://investors.biontech.de/news-releases/news-release-details/statement-patent-infringement-lawsuit-filedmoderna	https://investors.biontech.de/news-releases/news-release-details/statement-patent-infringement-lawsuit-filedmoderna	NOUN
blsr-16013	77	33	.	.	PUNCT
blsr-16013	78	1	14	14	NUM
blsr-16013	78	2	jon	jon	PROPN
blsr-16013	78	3	cohen	cohen	PROPN
blsr-16013	78	4	,	,	PUNCT
blsr-16013	78	5	“	"	PUNCT
blsr-16013	78	6	scientists	scientist	NOUN
blsr-16013	78	7	question	question	VERB
blsr-16013	78	8	moderna	moderna	PROPN
blsr-16013	78	9	invention	invention	PROPN
blsr-16013	78	10	claim	claim	NOUN
blsr-16013	78	11	in	in	ADP
blsr-16013	78	12	covid-19	covid-19	PROPN
blsr-16013	78	13	vaccine	vaccine	NOUN
blsr-16013	78	14	dispute	dispute	NOUN
blsr-16013	78	15	.	.	PUNCT
blsr-16013	78	16	”	"	PUNCT
blsr-16013	79	1	science	science	NOUN
blsr-16013	79	2	,	,	PUNCT
blsr-16013	79	3	29	29	NUM
blsr-16013	79	4	august	august	PROPN
blsr-16013	79	5	2022	2022	NUM
blsr-16013	79	6	,	,	PUNCT
blsr-16013	79	7	https://www.science.org/content/article/scientists-question-moderna-invention-claim-covid-19-vaccine-dispute	https://www.science.org/content/article/scientists-question-moderna-invention-claim-covid-19-vaccine-dispute	NOUN
blsr-16013	79	8	.	.	PROPN
blsr-16013	79	9	9	9	NUM
blsr-16013	79	10	specifically	specifically	ADV
blsr-16013	79	11	mrna	mrna	PROPN
blsr-16013	79	12	technology	technology	NOUN
blsr-16013	79	13	,	,	PUNCT
blsr-16013	79	14	can	can	AUX
blsr-16013	79	15	be	be	AUX
blsr-16013	79	16	a	a	DET
blsr-16013	79	17	hindrance	hindrance	NOUN
blsr-16013	79	18	to	to	ADP
blsr-16013	79	19	inoculation	inoculation	NOUN
blsr-16013	79	20	during	during	ADP
blsr-16013	79	21	the	the	DET
blsr-16013	79	22	ongoing	ongoing	ADJ
blsr-16013	79	23	pandemic	pandemic	NOUN
blsr-16013	79	24	as	as	SCONJ
blsr-16013	79	25	patent	patent	NOUN
blsr-16013	79	26	license	license	NOUN
blsr-16013	79	27	fees	fee	NOUN
blsr-16013	79	28	can	can	AUX
blsr-16013	79	29	increase	increase	VERB
blsr-16013	79	30	the	the	DET
blsr-16013	79	31	price	price	NOUN
blsr-16013	79	32	of	of	ADP
blsr-16013	79	33	vaccines	vaccine	NOUN
blsr-16013	79	34	.	.	PUNCT
blsr-16013	80	1	it	it	PRON
blsr-16013	80	2	is	be	AUX
blsr-16013	80	3	important	important	ADJ
blsr-16013	80	4	to	to	PART
blsr-16013	80	5	remember	remember	VERB
blsr-16013	80	6	that	that	SCONJ
blsr-16013	80	7	the	the	DET
blsr-16013	80	8	public	public	NOUN
blsr-16013	80	9	is	be	AUX
blsr-16013	80	10	still	still	ADV
blsr-16013	80	11	at	at	ADP
blsr-16013	80	12	risk	risk	NOUN
blsr-16013	80	13	,	,	PUNCT
blsr-16013	80	14	with	with	ADP
blsr-16013	80	15	33	33	NUM
blsr-16013	80	16	%	%	NOUN
blsr-16013	80	17	of	of	ADP
blsr-16013	80	18	the	the	DET
blsr-16013	80	19	u.s	u.s	PROPN
blsr-16013	80	20	.	.	PROPN
blsr-16013	80	21	and	and	CCONJ
blsr-16013	80	22	39	39	NUM
blsr-16013	80	23	%	%	NOUN
blsr-16013	80	24	of	of	ADP
blsr-16013	80	25	the	the	DET
blsr-16013	80	26	world	world	NOUN
blsr-16013	80	27	population	population	NOUN
blsr-16013	80	28	not	not	PART
blsr-16013	80	29	fully	fully	ADV
blsr-16013	80	30	vaccinated.15	vaccinated.15	VERB
blsr-16013	80	31	one	one	PRON
blsr-16013	80	32	might	might	AUX
blsr-16013	80	33	argue	argue	VERB
blsr-16013	80	34	that	that	SCONJ
blsr-16013	80	35	the	the	DET
blsr-16013	80	36	moderna	moderna	PROPN
blsr-16013	80	37	lawsuit	lawsuit	NOUN
blsr-16013	80	38	is	be	AUX
blsr-16013	80	39	justifiable	justifiable	ADJ
blsr-16013	80	40	because	because	SCONJ
blsr-16013	80	41	they	they	PRON
blsr-16013	80	42	are	be	AUX
blsr-16013	80	43	protecting	protect	VERB
blsr-16013	80	44	their	their	PRON
blsr-16013	80	45	rights	right	NOUN
blsr-16013	80	46	under	under	ADP
blsr-16013	80	47	the	the	DET
blsr-16013	80	48	u.s	u.s	PROPN
blsr-16013	80	49	.	.	PROPN
blsr-16013	80	50	constitution	constitution	PROPN
blsr-16013	80	51	.	.	PUNCT
blsr-16013	81	1	in	in	ADP
blsr-16013	81	2	reality	reality	NOUN
blsr-16013	81	3	,	,	PUNCT
blsr-16013	81	4	however	however	ADV
blsr-16013	81	5	,	,	PUNCT
blsr-16013	81	6	the	the	DET
blsr-16013	81	7	case	case	NOUN
blsr-16013	81	8	brings	bring	VERB
blsr-16013	81	9	awareness	awareness	NOUN
blsr-16013	81	10	to	to	ADP
blsr-16013	81	11	the	the	DET
blsr-16013	81	12	ethical	ethical	ADJ
blsr-16013	81	13	dilemma	dilemma	NOUN
blsr-16013	81	14	of	of	ADP
blsr-16013	81	15	whether	whether	SCONJ
blsr-16013	81	16	intellectual	intellectual	ADJ
blsr-16013	81	17	property	property	NOUN
blsr-16013	81	18	rights	right	NOUN
blsr-16013	81	19	should	should	AUX
blsr-16013	81	20	be	be	AUX
blsr-16013	81	21	prioritized	prioritize	VERB
blsr-16013	81	22	over	over	ADP
blsr-16013	81	23	life	life	NOUN
blsr-16013	81	24	-	-	PUNCT
blsr-16013	81	25	saving	save	VERB
blsr-16013	81	26	technology	technology	NOUN
blsr-16013	81	27	.	.	PUNCT
blsr-16013	82	1	15	15	NUM
blsr-16013	82	2	the	the	DET
blsr-16013	82	3	visual	visual	ADJ
blsr-16013	82	4	and	and	CCONJ
blsr-16013	82	5	data	datum	NOUN
blsr-16013	82	6	journalism	journalism	NOUN
blsr-16013	82	7	team	team	NOUN
blsr-16013	82	8	,	,	PUNCT
blsr-16013	82	9	“	"	PUNCT
blsr-16013	82	10	covid	covid	VERB
blsr-16013	82	11	vaccines	vaccine	NOUN
blsr-16013	82	12	:	:	PUNCT
blsr-16013	82	13	how	how	SCONJ
blsr-16013	82	14	fast	fast	ADV
blsr-16013	82	15	is	be	AUX
blsr-16013	82	16	progress	progress	NOUN
blsr-16013	82	17	around	around	ADP
blsr-16013	82	18	the	the	DET
blsr-16013	82	19	world	world	NOUN
blsr-16013	82	20	?	?	PUNCT
blsr-16013	82	21	”	"	PUNCT
blsr-16013	83	1	bbc	bbc	PROPN
blsr-16013	83	2	news	news	PROPN
blsr-16013	83	3	,	,	PUNCT
blsr-16013	83	4	1	1	NUM
blsr-16013	83	5	june	june	PROPN
blsr-16013	83	6	2022	2022	NUM
blsr-16013	83	7	,	,	PUNCT
blsr-16013	83	8	https://www.bbc.com/news/world-56237778	https://www.bbc.com/news/world-56237778	NOUN
blsr-16013	83	9	.	.	PUNCT